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CHAPTER 1
INTRODUCTION
Mechanical forces play a vital role in controlling several cellular and physiological
processes. (Vial et al., 2003; Czirok et al., 2004; Ewald et al., 2008; Gieni and Hendzel,
2008). For example, the migration of cultured cells have been shown to be guided by
the strength of adhesion between integrins and extracellular ligands, the amount of
traction stress generated by the cell onto the substrate (Munevar et al., 2001), and the
rigidity of the substrate (Lo et al., 2000b). Similarly, during tissue repair the isometric
tension generated by contractile myofibroblast cells helps to close the wound edges
(Desmouliere et al., 2005). Likewise, the stiffening of a tumor mass due to extracellular
protein deposition is predicted to influence cancer progression (Desmouliere et al.,
2005). These examples suggest that mechanical factors are as important as
biochemical factors to the regulation of cellular and tissue behavior. Likewise, any
changes in mechanical factors could result in disease progression such as, tumor
formation and metastasis.
Cellular changes in biochemical, genetic and biological properties have been well
documented for tumor cell invasion and metastasis. In contrast, changes in mechanical
properties of tumor cells and their substrate during metastatic progression are currently
ill defined. To understand the role of mechanical forces in the process of metastasis
new conceptual approaches are necessary pertaining to tumor cell dissemination.
Cancer can be defined as uncontrolled proliferation, invasion and inappropriate
migration of cells and is recognized as the leading cause of death worldwide (Hanahan
and Weinberg, 2000). When tumor cells break through the basement membrane and
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invade the surrounding stromal tissues, metastasis is defined. The metastatic cascade
is a sequential process in which cells from the primary tumor invade the neighboring
tissues, travel through the blood stream and colonize in distant tissues (Liotta et al.,
1991; Felding-Habermann et al., 2001; McDonald and Baluk, 2002). To successfully
migrate and colonize, the cancer cells must adhere to the surrounding matrix in the
stromal compartment and subsequently within a distant tissue, where they will form a
secondary tumor. Foreign tissue microenvironments may differ in extracellular matrix
(ECM) rigidity and tissue rheology from the primary tumor tissue (Paszek et al., 2005).
In order to colonize in the new microenvironment, cancer cells must adapt themselves
to respond not only to different biochemical signals, but also to changes in the
biophysical cues of the environment (Joyce and Pollard, 2009; Kumar and Weaver,
2009a). Indeed, a tumor cell makes several adaptations in response to biophysical cues
including the loss of cell-cell adhesion, alteration of integrin expression, rearrangement
of cytoskeleton structure, and increased mobility (Guo and Giancotti, 2004b; Bissell et
al., 2005).
Epithelial to Mesenchymal Transition
Epithelial to Mesenchymal Transition (EMT) plays a vital role in tissue
morphogenesis, body patterning, wound healing and development (Martin and
Parkhurst, 2004; Ewald et al., 2008). EMT is described by partial or complete loss of
epithelial cell-type characteristics and gain of mesenchymal cell-like properties. At the
cellular level the process of EMT results in the loss of apico-basal polarity and
disassembly of adherens junctions of epithelial cells (Peinado et al., 2004; Townsend et
al., 2008). These changes are due to the replacement of E-cadherin with N-cadherin
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and intermediate filaments with vimentin and are considered as the molecular hall
marks of EMT (Ikenouchi et al., 2003). Together these changes alter the epithelial
cytoskeleton structure and transition the cell to the spindle shaped mesenchymal
phenotype (Micalizzi et al., 2010). During this transition process, epithelial cells are also
known to acquire highly invasive and migratory properties (Guarino et al., 2007). A large
number of studies suggest that this epithelial plasticity is also involved in pathological
conditions including fibrosis and tumor cell metastasis (Lopez-Novoa and Nieto, 2009).
Nonetheless, despite extensive reports in the literature, the importance of EMT to
cancer metastasis remains controversial, basically due to the lack of pathological
evidence at the site of the secondary tumor.
The Role of Mechanical Forces in Tissue Integrity and Disease Progression
Individual cells in multicellular organisms are subjected to different types of
forces including tensile and fluid shear stresses. In response to extracellular forces, the
cell exerts reciprocal forces through a phenomenon referred to as mechanoreciprocity
(DuFort et al., 2011). At least two kinds of forces are produced by the cell at the cellsubstrate interface. The first are actin-myosin generated contractile forces, known as
traction force (Lauffenburger and Horwitz, 1996; Sheetz et al., 1998). Traction forces
are produced by the cell during the process of active migration. The second cellsubstrate force is generated by the cytoskeleton which helps to maintain tensional
homeostasis (Butcher et al., 2009). A proper balance between extracellular and cell
generated forces are necessary to maintain adult tissue homeostasis. For example, the
growth of skeletal muscle tissue depends on mechanical loading (Bird et al., 2000),
similarly shear stress of blood flow maintains the health of vascular tissues (Takahashi
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et al., 1997). However, each tissue has its unique characteristic range of mechanical
stiffness which changes to an optimum level over time either during development or
during a change of function (Butcher et al., 2009). In addition to these naturally
occurring changes, drastic changes or loss of tissue homeostasis occurs during the
onset of disease as seen in fibrosis or tumor formation (Paszek et al., 2005; Wells,
2005).
Tumor growth is associated with excessive ECM deposition and thereby palpable
stiffening of the tissue (Garra, 2007). Tumor tissue also encounters excessive
compressive stress due to uncontrolled cell proliferation which leads to increase in
interstitial pressure (Paszek and Weaver, 2004b). Disruptions of tensional homeostasis
in the tumor microenvironment is predicted to influence cellular biophysical properties
including cellular morphology, cell motility, cytoskeleton organization, traction force
production and cell-substrate adhesion (Paszek et al., 2005). Moreover, it has been
shown that malignant transformation of normal fibroblasts are associated with changes
in traction force production (Munevar et al., 2001).
Cellular Mechanotransduction Machinery
The mechanotransduction machinery of cells includes mechanosensors and
force generating molecules that enable cells to counteract forces in the in-vivo
environment. For example, calcium gated ion channels (Parker and Ingber, 2007),
cadherin complexes (Tzima et al., 2005) and transmembrane protein integrin (van der
Flier and Sonnenberg, 2001; Helmke et al., 2003) have been shown to act as cellular
mechanosensors whereas the actin cytoskeleton is known to be the cellular force
producing tool (Sanger et al., 1983; Bereiter-Hahn, 2005). When mechanical cues are
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received at the cell-cell or cell-substrate interface the signal is transmitted to the cell
interior by sequential activation of signaling molecules a process known as outside-in
mechanotransduction (Qin et al., 2004). At the cell-substrate interface the outside-in
mechanotransduction pathway is initiated when specialized anchoring junctions, known
as focal complexes are established (Partridge and Marcantonio, 2006a). The assembly
of a focal complex begins with the formation of adhesive contact between the
extracellular ligand and the integrin (Figure 1.1). Integrin-ligand interaction leads to the
conformational changes in the integrin resulting in activation of the molecule (Campbell
and Humphries, 2011). The active form of integrin favors integrin clustering, recruits a
large number of signaling molecules such as, talin, vinculin, src and focal adhesion
kinases (FAK) (Margadant et al., 2011) and establishes a link between the actin
cytoskeleton and the extracellular ligand (Paszek et al., 2009). Once the cytoskeleton
link is established, actomyosin contractility at the adhesion junction promotes the
formation of focal adhesions, increased tyrosine phosphorylation of focal adhesion
kinase and interactions between multiple signaling complexes to promote growth,
migration and differentiation (Miranti and Brugge, 2002; Berrier and Yamada, 2007).
Given the importance of outside-in signaling, it is obvious that mechanical changes in
extracellular environment lead to changes in focal adhesion parameters and altered
mechano-signaling cascades.
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Figure 1.1. Components of cellular mechanotransduction. Integrin mediated cell
adhesion establishes a linkage between ECM and actin cytoskeleton. Contractile force
generated by actin cytoskeleton is resisted by the stiffness of the ECM and enable cells
to probe the matrix elasticity at the resolution of cell-matrix adhesion. Stiffer matrix
produces higher reciprocal forces which facilitates integrin oligomerization, formation
and recruitment of focal adhesion proteins, and FAK phosphorylation.
Integrin in Mechanotransmission
Among the wide array of membrane receptor proteins present at the cellsubstrate interface, integrin has been one of the best studied of these transmembrane
receptor proteins. Integrins are a large family of heterodimeric glycoproteins composed
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of α and β subunits responsible for linking the actin cytoskeleton to the ECM. The
integrin family includes at least 18 α and 8 β subunits forming more than 24 different
functional receptors (Calderwood, 2004). Many studies suggest that integrins serve as a
bi-directional mechanotransducers (Hynes, 1992; Lewis and Schwartz, 1995; Ingber,
2003). Integrins permit the cells to detect the extracellular force at the resolution of
individual adhesion sites (Felsenfeld, 2005). Conversely, it transmits the actin-myosin
generated traction force back out into the surrounding environment through the focal
adhesions (Bershadsky et al., 2003a). In recent years, it was found that integrin αvβ3,
acts as a rigidity sensor at the leading edge of a fibroblast (Jiang et al., 2006b). Thus
the structure and functions of this important molecule including its affinity to extracellular
ligand, activation and clustering are tightly regulated by cell-ECM interaction (Sims et
al., 1991; Woodside et al., 2001). The active form of integrin turns on several signaling
pathways important for adhesion, migration, proliferation and assembly of extracellular
matrix (Huttenlocher et al., 1996; Martin-Bermudo and Brown, 2000; Assoian and Klein,
2008).
Integrins in Cancer
Differential expression of various integrin receptors on cancer cells is thought to
be associated with differences in metastatic behavior (Shaw et al., 1999) and
malignancy (Friedrichs et al., 1995; Mukhopadhyay et al., 1999). For example, during
breast cancer metastasis several integrins such as α6β4, αvβ3 are up-regulated
whereas several other integrins such as, α5β1, αvβ1, α1β1, α2β1 and α3β1 have been
shown to be down regulated (Bartsch et al., 2003). Based on this observations, it is
logical to predict that integrin expression changes with the alteration of cellular and
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extracellular forces. Furthermore, given the diversity of mechanical environments they
must traverse, it reasonable to predict that as tumor cells become more metastatic, they
likely suppress their normal mechanotransduction ability.
Changes in Cell Migration during Metastasis
Migration of a cell is a tightly regulated sequential event that begins with the
polymerization of actin cytoskeleton and protrusion of the leading edge. The protruding
edge establishes a new adhesion sites to the underlying substrate by integrin and focal
adhesion components (Balaban et al., 2001). The newly established adhesion sites not
only stabilize the actin filaments but also serve as the site for producing traction stress
(Tan et al., 2003). In addition to adhesion at the cell front, cell-ECM engagement
disassembles at the rear allowing cell to propel forward (Iwanicki et al., 2008). Thus cell
adhesions, dehadhesions and actin generated contractile forces are the critical steps for
cell motility (Figure 1.2). Any changes in adhesion or defects in cytoskeleton contractility
can lead to abnormal cell motility, and potentially- invasion and metastasis. The higher
migratory capacity of cancer cells presumably comes from their ability to use different
modes of migration in a context dependent manner (Poincloux et al., 2011). For
example, a number of studies elucidated that tumor cells follow the mesenchymal mode
of adhesion dependent migration for invading the surrounding tissues (Sahai and
Marshall, 2003). However, other studies showed that tumor cells follow less adhesive,
amoeboid mode of migration (Wolf et al., 2003). From these, it is imperative that the
major cause of cancer related death results from altered cell adhesion and motility.
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Figure 1.2. Illustration of cell migration. Actin polymerization results in extension of the
leading edge and the establishment a contact with the underlying matrix. Cytoskeleton
generated traction stress at the site of adhesion drags the cell body forward while
release of cell-substrate contact at the rear causes the forward locomotion of cell.
Cellular Response to Changes in Extracellular Compliance and Composition
The extracellular matrix is a complex mixture of proteins with a large variety of
biochemical and biophysical properties. It has been shown that a number of cellular
activities including migration, proliferation and apoptosis are guided by this insoluble
protein component (Boudreau and Jones, 1999). Based on the structural localization the
extracellular matrix can be divided into two broad categories - basement membrane and
interstitial matrix. As the name suggests the basement membrane is found under the
basal side of polarized epithelial cells and separates the epithelial cells from connective
tissue enriched stromal environment. This thin layer of ECM proteins is primarily
composed of laminin and type IV collagen. The second category, interstitial matrix,
primarily consists of type I collagen and is present within the epithelial cells to provide
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mechanical stability (Guo and Giancotti, 2004b). Each of these categories of ECM has
its unique characteristics of protein composition and biophysical properties. These
properties are not static and can change dramatically through remodeling steps during
wound healing and development. Structural changes in the ECM include degradation,
assembly and deposition which lead to changes in rigidity and ligand concentration
(Butcher et al., 2009) ultimately affecting cellular behavior. Cells are known to respond
to changes in substrate stiffness by migrating towards a more rigid location, this is a
phenomenon known as durotaxis (Lo et al., 2000b). Due to mechanoreciprocity, the
magnitude of traction forces is also dependent on rigidity. For example, on stiffer
substrates cells generate more traction force and develop a flatter morphology than they
do on softer substrate (Lo et al., 2000b). However, this compliance dependent response
is known to be cell type specific and cells are thought to prefer their host tissue rigidity
(Georges and Janmey, 2005). For example, spinal cord derived motor neurons that
have originated from softer tissue microenvironments extend neuritis only on softer
substrate (Flanagan et al., 2002). In contrast smooth muscle cells and fibroblasts exist
within relatively rigid environments and thus extend processes more avidly on hard
substrate (Engler et al., 2004b; Yeung et al., 2005a). However, extracellular stiffness
also changes during the progression of disease. During tumor progression for example,
the rigidity changes within a tumor and within its stroma (Paszek and Weaver, 2004b).
However, how these changes affect metastatic cancer cells and multiple stages of the
metastatic cascade is poorly understood.
In addition to rigidity, cellular response has been shown to be modulated by the
combination integrin-ligand interaction (Chan et al., 1992). Several studies showed that
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both extracellular ligands and their receptor integrin exhibit redundancy in their
specificity for binding with each other. For example integrin αvβ3 shows strong affinity
for both vitronectin and fibronectin. Similarly fibronectin can bind with multiple numbers
of integrin receptors including α5β1, α3β1 and αvβ3. (Boudreau and Jones, 1999). This
overlapping integrin-ligand interaction suggests that each combination of integrin-ligand
adhesion has specialized function (Boudreau and Jones, 1999). Because integrin
expression is known to be modulated during development and disease, it is necessary
to understand the particular combination of integrin-ligand interaction involved in
sensing the mechanical rigidity and how that interaction changes with metastatic
progression.
Cellular Response to Localized Stimulation
In addition to sensing changes in rigidity, a second type of mechanical signal
could result from pulling on ECM fibers by highly contractile neighboring cells (Menon
and Beningo, 2011). Almost every cell of our body encounters this localized pulling
force during a functional change and during development. For example, the contractile
forces generated by myofibroblast cells help to bring the wound edges together during
tissue repair (Hinz, 2007). Another example is, in the mammary gland, localized
contractile forces generated by myoepithelial cells play a critical role during lactation
(Raymond et al., 2011). Furthermore, mammary gland associated stroma is enriched
with highly contractile cells of fibroblastic origin (Kunz-Schughart and Knuechel, 2002;
Schor et al., 2003). Stromal fibroblasts are known to modulate the ECM architecture by
matrix remodeling and contraction during mammary gland development and tumor
formation (Kammertoens et al., 2005; Shieh et al., 2011). Not surprisingly, tumor
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formation simulates many of same responses seen in wound healing (Kalluri and
Zeisberg, 2006). Despite the knowledge of stromal interaction in mammary gland
morphogenesis and tumor development the mechanical role of these stromal cells is
poorly defined. The role of these contractile cells in modifying the ECM architecture
(Paszek and Weaver, 2004b), secretion of growth factors (Powell et al., 1999) and
prevention of immune response to cancer cells (Lieubeau et al., 1999) have already
been studied, however the influence of tugging and pulling produced by these cells has
been overlooked. Because cells within in-vivo environment are likely to encounter
dynamic environmental rigidity and localized applied stimulation, it is important to
understand the cellular response when both the mechanical forces are present within
the cellular microenvironment.
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CHAPTER 2
AN IN-VITRO CORRELATION OF MECHANICAL FORCES AND METASTATIC
CAPACITY
This chapter has been published
Indra, I., Undyala, V., Kandow, C., Thirumurthi, U., Dembo, M., and Beningo, K.A.
(2011). An in-vitro correlation of mechanical forces and metastatic capacity. Phys Biol 8,
015015. © 2011 IOP Publishing Ltd Printed in the UK
ABSTRACT
Mechanical forces have a major influence on cell migration and are predicted to
significantly impact cancer metastasis, yet this idea is currently poorly defined. In this
study we have asked if changes in traction stress and migratory properties correlate
with the metastatic progression of tumor cells. For this purpose, four murine breast
cancer cell lines derived from the same primary tumor, but possessing increasing
metastatic capacity, were tested for adhesion strength, traction stress, focal adhesion
organization and for differential migration rates in two-dimensional and threedimensional environments. Using Traction Force Microscopy (TFM), we were surprised
to find an inverse relationship between traction stress and metastatic capacity, such that
force production decreased as the metastatic capacity increased. Consistent with this
observation, adhesion strength exhibited an identical profile to the traction data. A count
of adhesions indicated a general reduction in the number as metastatic capacity
increased but no difference in the maturation as determined by the ratio of nascent to
mature adhesions. These changes correlated well with a reduction in active beta-1
integrin with increasing metastatic ability. Finally, in two-dimensions, wound healing,
migration and persistence were relatively low in the entire panel, maintaining a
downward trend with increasing metastatic capacity. Why metastatic cells would migrate
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so poorly prompted us to ask if the loss of adhesive parameters in the most metastatic
cells indicated a switch to a less adhesive mode of migration that would only be
detected in a three-dimensional environment. Indeed, in three-dimensional migration
assays, the most metastatic cells now showed the greatest linear speed. We conclude
that traction stress, adhesion strength and rate of migration do indeed change as tumor
cells progress in metastatic capacity and do so in a dimension sensitive manner.
INTRODUCTION
The migration of mammalian cells is fundamental to normal embryonic
development, tissue repair and immune function (Lauffenburger and Horwitz, 1996;
Ridley et al., 2003; Chodniewicz and Klemke, 2004; Vandenberg, 2008). Under normal
physiological conditions, most cells migrate in an adhesion dependent manner involving
the formation of adhesions at the cell-substrate interface and the subsequent generation
of mechanical forces via the actin-myosin network (Fournier et al., 2010). Adhesion
formation begins with the interaction between extra-cellular matrix proteins (ECM) and
integrin receptors (Riveline et al., 2001; Calderwood, 2004; Gallant et al., 2005; Shattil
et al., 2010). What follows this initial interaction is under intense study and involves
orchestrated protein recruitment and phosphorylation events resulting in the linkage of
select adhesions to the actin-myosin network. Mechanical forces produced by the
contraction of this network can be measured outside of the cell as traction stress
(Lauffenburger and Horwitz, 1996; Li et al., 2007). The full purpose of these forces
continues to be defined, but represent a variety of activities involving propulsion,
probing and matrix remodeling (Thomas and DiMilla, 2000; Bershadsky et al., 2003a; Li
and Wang, 2009). Nonetheless, their requirement in multiple normal cellular processes
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including cell division, adhesion, and migration is well documented (Fournier et al.,
2010). What remains to be established is the importance of traction stress in disease
states, such as cancer and fibrosis (Mierke et al., 2008).
Tumor cells have long been known to differ from normal cells in adhesive and
contractile strength resulting in abnormal growth and migratory behaviors (Thomas and
DiMilla, 2000; Rabinovitz et al., 2001; Friedl and Wolf, 2003). Conflicting studies of
individual cell lines have found both reduced and increased traction stress produced in
cells after oncogenic transformation, hinting at the importance of traction stress in
cancer (Munevar et al., 2001).

However no studies have done so far to show how

traction stress change as cells progress through different stages of metastasis. Several
significant studies have also focused on how the compliance (stiffness) of the tumor
micro-environment promotes tumor growth (Paszek et al., 2005; Assoian and Klein,
2008; Ronnov-Jessen and Bissell, 2009). However, 90% of deaths result from the
metastatic phase of the disease and not the primary tumor. As tumors progress to the
multi-step process of metastasis their motility changes drastically often taking on
adhesion-independent modes of migration after leaving the primary tumor environment.
Although studies have looked at compliance and the metastatic state (Kostic et al.,
2009), how changes in cell-generated traction stress and cell-substrate adhesion
strength change throughout the progression of the metastatic phase is unknown .
Inappropriate migration of a tumor cell from the primary tumor is an early step in
the process of metastasis. Subsequent cascade of events include, invasion of tumor
cells into the stroma, intravasion into the lymphatics and blood circulation, extravasation
into the secondary site and finally the formation of a secondary tumor at distant tissue
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(Banyard and Zetter, 1998; Fidler, 2003; Mierke et al., 2008).

This malignant

transformation of epithelial derived tumor cells is thought to be associated with an
epithelial to mesenchymal transition in which carcinoma cells downregulate the
epithelial proteins E-cadherin, and cytokeratin in exchange for expression of the
mesenchymal proteins N-cadherin, vimentin, and fibronectin (Ke et al., 2008; Mani et
al., 2008; Sarrio et al., 2008).
To our knowledge, despite evidence that migration, adhesion and traction stress
are aberrant in isolated cancer cell lines, none of these parameters have been
correlated with the progressive stages of cancer metastasis. In this study, we used four
murine breast cancer cell lines derived from a single primary tumor, but capable of
completing different stages of metastasis and ask if indeed changes in these
parameters coincide with the degree of metastatic aggressiveness.

Because these

cells come from the same tumor, within the same mouse, they offer a significant
advantage over using multiple cell lines derived from multiple different genetic
backgrounds that confound interpretation. In this study, we find that traction stress, in
two-dimensional cultures, and cell-substrate adhesion strength decrease as metastatic
capacity increased in this panel. We also observed a general reduction of migration
efficiency in two-dimensional cultures during single cell and collective migration, despite
the organization of focal adhesion and actin cytoskeleton structure being grossly
unaffected. However, we also found a reduction in the total number of focal adhesion
and the level of active beta-1 integrin as the metastatic capacity increased.

We

interpreted this as a gradual shift towards a less adhesion-dependent mode of
migration, one that can only be measured in three-dimensions. As predicted, the highest
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migration speeds in three-dimensional cultures were observed in the most metastatic
cells of the panel, despite the low levels of active beta-1 integrin. Our results enhance
our understanding of the significance of traction stress in metastatic progression and reenforce the need for con-current three-dimensional studies of these forces.
Nonetheless, our study suggests that two-dimensional analysis of traction, migration
and adhesion can be reflective of the metastatic capacity of a cell and could potentially
be a useful prognostic tool.
MATERIALS AND METHODS
Cell Culture and Preparation of Polyacrylamide Substrates
Four sub-populations of murine breast cancer cell lines derived from the same
primary tumor but possessing different metastatic potential (generous gift from Dr. Fred
Miller, Karmanos Cancer Institute), and normal murine mammary gland cell line was
purchased from ATCC. Cultures were maintained in Dulbecco’s Modified Eagle’s
Medium containing 10% fetal bovine serum (Hyclone, UT, USA), and supplemented
with100 U/ml penicillin, 2 mM L-glutamine, and 100μg/ml streptomycin. Cells were
grown in a standard culture incubator at 37°C with 5% CO 2. Adhesion assays and
Traction Force Microscopy (TFM) were performed as described previously (Beningo et
al., 2002a; Undyala et al., 2008). The hydrogels were covalently coated with 5 μg/cm 2
bovine plasma fibronectin (Sigma, Saint Louis, USA). A concentration of 5% acrylamide,
and 0.08% N,Nmethylene-bis-acrylamide were used to prepare the substrates for this
study.
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Microscopy
An Olympus IX81 ZDC inverted microscope was used to acquire both phase
contrast and fluorescence images. The objective lenses used for these studies were the
10X/0.25 NA CP-Achromat lens for phase contrast images and 40X/0.75 NA PlanNeofluar lens for fluorescence images. Temperature control and CO2 were maintained
by a custom built stage incubator when live cell imaging was performed.
Determination of Traction Stress
Traction stress was measured as previously described (Beningo et al., 2001). In
brief, flexible polyacrylamide substrates (5% acrylamide and 0.08% bis-acrylamide),
coated with extracellular matrix protein fibronectin for cell adhesion and embedded with
fluorescent microbeads for tracking the deformation on the substrate. The elasticity of
the substrate was determined to be 2.4X10 4 N/m2 by indentation and the Hertz equation
as described (Lo et al., 2000b). Prior to taking the traction force measurements, cells
were cultured for 24 hours on the substrates. Stressed and null images were obtained
by first imaging the beads in the presence of the cell, followed by removal of the cell
with a microneedle. Analysis of the data was carried out using LIBtrc custom software to
calculate the average integrated traction stress as described (Dembo and Wang, 1999;
Marganski et al., 2003).
Cell Adhesion Assay
A centrifugation assay was performed to measure the strength of cell-substrate
adhesion as described earlier with slight modification (Guo et al., 2006a). Briefly,
approximately 2.5x104 cells were seeded on to fibronectin-coated polyacrylamide
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substrate (5% acrylamide and 0.08% bis-acrylamide) in specifically designed chambers.
The cells were then allowed to adhere for 30 minutes at 37°C. The chambers were
centrifuged in a Beckman (Fullerton, CA) TJ-6 centrifuge at 1800xg for 5 minutes. The
strength of adhesion was determined as the percentage of cells remaining adhered to
the substrate after centrifugation. At least three sets of experiments were done and ten
fields of cells were counted for each for each cell type.
Cell Migration Assays
The migrations of breast cancer and control cell lines were monitored by time
lapse video microscopy with 40X magnification.

Two-dimensional migration was

performed as previously described (Shiu et al., 2004). In brief, cells were seeded at low
density onto fibronectin or collagen coated no.1 coverglass slides and incubated
overnight at 37ºC. Phase contrast images of a single cell were acquired at 2-min
intervals and transferred from a frame grabber to computer storage. Three-dimensional
collagen gel migration assays were performed as previously described (Niggemann et
al., 2004). Briefly, 1x105cells/ml were suspended in buffered liquid collagen type-I at a
final concentration of 1.65mg/ml (pH 7.4; 3mg/ml; Pure Col, Advanced Biomatrix, USA).
Self-constructed glass chambers were filled with 400µl of suspension, sealed and
incubated at 37ºC. Following polymerization, sequential phase images were collected
as above. The three-dimensional fibrin-fibronectin migration assay was performed as
previously described (Brown et al., 1993). In short, 1x106 cell were suspended in 350µl
of DME (25mM HEPES) and mixed with 200µl platelet poor human plasma collected in
sodium Citrate (Innovative Research, Novi, MI, USA). The suspension was placed into
7.25x55mm glass tubes (Bio Data corporation, USA). 200µl of HEPES DMEM

20

containing 28mM CaCl2 and 5U/ml human thrombin (Innovative Research, Novi, MI,
USA) was then added to the tube, mixed and incubated at 37ºC for 3hrs to generate the
clot. The clot was transferred to a self-contained glass chamber and phase contrast
images were acquired as above. The custom designed Dynamic Image Analysis
System software (DIM; Y.-L Wang) was used to determine the x, y coordinates of cell
centroids from the phase images and to track the path of each cell during migration. The
migration speed (microns/minutes) and persistence (minutes) were calculated by
quantifying the centroid displacement every 2 minutes over a 120 minute period.
Migration speed is shown as +/- S.E. Only isolated and well-spread cells were used for
migration analysis. At least ten individual cells were pooled from each cell line for these
assays.
Scratch Wound Assay
To perform the scratch wound assay, cells were cultured on fibronectin coated
glass surface (5μg/cm2), until the formation of a tight monolayer. As described earlier
(Rajasekaran et al., 2001) the confluent monolayer was then scratched with a sterile
200µl pipette tip to create a uniform, cell free area with a width of approximately 1mm.
Cell debris was removed by washing with fresh 37ºC culture medium and incubated for
30 minutes at 37ºC. Wound closure was monitored by time lapse microscopy for a
period of 24 hours at 20 minutes intervals. At least three different wounds for each cell
line were monitored. The percentage of the wound filled in micrometers was determined
using Image J software (NIH) as the average distance from the wound origin covered by
cells 24 hours after wounding.
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Immunofluorescence
Cells adhered to no.1 coverglass coated with fibronectin (5μg/cm 2) were washed
with warm cytoskeleton buffer (137mM NaCl, 5mM KCl, 1.1 mM Na2HPO4, 0.4mM
KH2PO4, 2mM MgCl2, 2mM EGTA, 5mM PIPES and 5.5 mM glucose, pH 6.1) and
fixed for immunofluorescence in 4% paraformaldehyde and 0.1% Triton X-100 for 10
minutes, followed by blocking 1 hour with 5% Bovine serum albumin (BSA). Fixed cells
were incubated with 1:50 Alexa Flour 546 phalloidin (Invitrogen, CA) for 1 hour, 1: 1000
anti-paxilin antibody (Clone 349, Chemicon International, USA) for 4 hours and 1:1000
Alexa Fluor 488 anti-mouse secondary (Invitrogen, CA) for 1 hour. All incubations with
antibody were done at room temperature unless otherwise specified. To obtain the
percentage of mature focal adhesions attached to stress fibers, an arbitrary line forward
of the nucleus of a highly polarized cell was drawn separating the cell body from the
leading edge. The number of Paxillin plaques that co-localized with actin fibers at the
leading edge were counted and divided by the total number of paxillin plaques. To
visualize the epithelial and mesenchymal markers, cells were incubated with either
1:1000 anti-E-Cadherin antibody (BD Biosciences, San Jose, CA, USA) or 1:1000 antiN-Cadherin antibody (BD Biosciences, San Jose, CA, USA) or 1:200 anti-fibronectin
antibody (Abcam Inc, Cambridge, MA, USA) overnight at 4 ºC followed by 1hour
incubation with Alexa Fluor 488/546 anti-mouse secondary (Invitrogen, CA). Collected
images were pseudo-colored and overlaid to identify areas of co-localization where
necessary.
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Western Blot Analysis
Cells cultured to 70% confluency on standard 100mm culture plates were rinsed
with ice cold 1X Phosphate Buffered Saline (PBS) and lysed in triple detergent lysis
buffer (2% NP40, 0.5% Deoxycholic acid and 0.2% SDS) along with protease inhibitors
(SIGMAFAST Protease Inhibitor, Sigma Aldrich, USA).

The protein content was

determined by the DC protein assay (Bio Rad, USA) according to manufacturer’s
instructions. Samples (50 μg of protein, unless otherwise specified) were subjected to
SDS-PAGE on 10% mini gels and transblotted onto PVDF membrane (Millipore). The
membrane was blocked in 5% Non-fat Dry milk, 0.1% Tween-20 in PBS for 2 hours at
room temperature before exposure to the primary antibody (except for vimentin which
was blocked in 0.1% Tween-20 in Tris Buffered Saline (TBS)). Antibody source and
concentration were as follows [1: 4000 mouse monoclonal E-Cadherin (Clone 36, BD
Biosciences, San Jose, CA, USA), 1:5000 mouse monoclonal N-Cadherin (Clone 32,
BD Biosciences, San Jose, CA, USA), 1:300 mouse monoclonal fibronectin (Clone IST9, Abcam Inc, MA, USA), 1:2500 mouse monoclonal vimentin (Clone RV202, BD
Pharmingen, San Jose, CA, USA), 1:1000 mouse monoclonal alpha tubulin (Clone B-51-2, Sigma, USA) and 1:7000 mouse monoclonal GAPDH (Clone 6C5, Chemicon
International, USA)]. Incubation with vimentin antibody was performed for 1 hour at
room temperature. Incubations with all other primary antibodies were performed
overnight at 4°C. The membranes were then incubated with secondary horseradishconjugated goat anti-mouse [BD Biosciences, San Jose, CA, USA (diluted 1:1000 for ECadherin, N-Cadherin, Vimentin, Fibronectin, and alpha tubulin; 1: 7000 for GAPDH)].
Signals were developed with the ECL detection kit (GE Health care).
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To determine the level of expression of active β1 integrin, polystyrene cell culture
plates were coated with either, 5µg/cm 2, 0.05µg/cm2 or no fibronectin (Sigma, USA) and
incubated overnight at 4°C. The plates were rinsed with sterile 1X PBS, blocked with
1% bovine serum albumin (BSA) and incubated overnight at 4°C. After blocking the
plates were rinsed with sterile 1X PBS and cells were seeded, harvested and lysed as
described above. Blots were probed with 1:500 rat anti-mouse monoclonal active β1integrin antibody (Clone 9EG7, BD Pharmingen, San Jose, CA, USA), and 1:7000
GAPDH served as an indicator of loading consistency.
RESULTS
Characterization of the Metastatic Panel
Four murine mammary carcinoma cell lines (67NR, 168FARN, 4TO7 and 66cl4)
were used in this study. This panel of cells originated from a single parental breast
tumor yet each has acquired a different capacity to complete the metastatic cascade, as
described by Aslaskon and Miller (1992) and summarized in Figure 2.1. Briefly, the first
cell line (67NR) is non-metastatic and forms only primary tumors, the second
(168FARN) can invade and enter the circulation, but cannot re-colonize; the third (4T07)
completes all steps of the metastatic cascade, but only forms micro-metastases, the
fourth (66cl4) can execute all of the steps required for the formation of a secondary
tumor, although it is considered to be only moderately aggressive (Aslakson and Miller,
1992).
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Figure 2.1. Characterization of the murine breast cancer cell lines. Phase images of the
normal mammary gland cell line and four mice breast cancer cell lines, along with their
metastatic potential and capacity to form the primary tumor when injected into mice.
This cell panel has been used in a number of studies and provides a powerful
tool for the study of metastasis in-vitro or in-vivo because they initially derive from the
same genetic background (Dexter et al., 1978; Aslakson and Miller, 1992; Giancotti and
Ruoslahti, 1999; Yang et al., 2004; Lou et al., 2008). Further, genetic profiling of this
panel has identified new proteins involved in different stages of the metastatic process.
One protein of interest is the transcription factor twist, which activates the
transdifferentiation program, known as epithelial-mesenchymal transition (EMT) (Yang
et al., 2004). This change from epithelial type morphology to a more migratory
phenotype is thought to be a requirement for metastasis of carcinoma cells. However,
the significance of this transition, and to what extent it must be completed for metastatic
relevance, is not entirely clear (Christofori, 2006; Lou et al., 2008; Voulgari and Pintzas,
2009).
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Typically, several proteins are used as markers to determine if the EMT
transdifferentiation has occurred. It is generally accepted that cells that have undergone
EMT may express N-cadherin (instead of E-cadherin), and higher levels of vimentin and
fibronectin (Kong et al., 2006; Sarrio et al., 2008). Cells that have retained the epithelial
phenotype generally express E-cadherin and lower levels of the other two markers. We
determined the state of EMT of this panel of breast tumor cells by immunofluorescence
and western blotting for these markers. Both 67NR and normal murine mammary gland
cells (NmuMg) served as controls, however 67NR is the true control as it comes from
the same mouse as the other cell lines and only forms primary tumors and does not
metastasize.
As expected, by immuno-fluorescence the epithelial marker E-cadherin was
expressed only at the cell-cell junction of normal murine mammary gland cells (Figure
1A). Surprisingly, the expression of the mesenchymal marker N-Cadherin, was
observed only in 67NR and 66cl4 (Figure 2.2(A)). Two intermediate cell lines, 168FARN
and 4T07, did not express either of these two proteins (Figure 2.2(A)). These
observations were further confirmed by western blot (Figure 2.2(B)).

26

Figure 2.2. The epithelial to mesenchymal transition is incomplete in the panel of breast
cancer cells. (A) Immunofluorescent images of E-cadherin and N-cadherin at the cell–
cell junction of Nmu Mg, 67NR and 66cl4. (B) Whole cell lysates of NmuMg (lane 1),
67NR (lane 2), 168FARN (lane 3), 4T07 (lane 4) and 66cl4 (lane 5) were prepared and
analyzed by western blot for the expression of E-cadherin, N-cadherin, vimentin and
fibronectin. Alpha-tubulin (50 kDa) was used as a load control for E-cadherin (120 kDa)
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and N-cadherin (130 kDa). GAPDH (38 kDa) was used as a load control for vimentin
(57 kDa) and fibronectin (52 kDa).
The expression of cellular fibronectin and the intermediate filament protein
vimentin were also observed by western blot. We found that vimentin was strongly
expressed by 67NR compared to the other cells (Figure 2.2(B)). On the other hand,
fibronectin was strongly expressed by 4T07 (Figure 2.2(B)). Surprisingly, 168FARN, the
cell line capable of leaving the primary tumor but unable to re-colonize, did not express
any of these proteins (Figure 2.2(B)). Our results, consistent with recent observation,
show that the EM transition is incomplete in all cells of the panel and suggests that a full
transition, as defined by this set of markers was not necessary for their metastatic
properties (Lou et al., 2008). Furthermore, our observations support the growing
contention that EMT may not always be a requirement for successful metastasis (Tarin
et al., 2005; Cowin and Welch, 2007).
Traction Stress is Inversely Related to Metastatic Capacity
The measurement of traction stress has provided valuable insight into the
process of cell migration, specifically into adhesion and contraction (Balaban et al.,
2001; Munevar et al., 2001; Geiger and Bershadsky, 2002; Mierke et al., 2008). A few
studies have found differences in traction stress when comparing cancer cells verses
normal cells (Munevar et al., 2001; Ghosh et al., 2008). However, to our knowledge, this
relationship has not been defined with regard to multiple stages of metastatic ability.
Using this unique panel of cancer cells, with their varying metastatic abilities, we have
asked whether metastatic capacity can be linked to changes in traction stress.
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For this study we have used traction force microscopy (TFM) to quantify the
stress transferred from the migrating cancer cells onto the underlying substrates. We
were surprised to discover that the traction stress of each of the cell panel members
decreased in a highly consistent manner as we progressed from cells of the least
aggressive in metastatic capacity to the cells that were most successful in establishing
secondary tumors. This inverse relationship was striking, as the least metastatic line
67NR produced the highest average traction stress (0.231 Pa) and the most metastatic
66cl4 line produced the least average traction stress (0.036 Pa) (Figure 2.3(A)).
Furthermore, as a general observation, the spatial organization of the stress vectors
were highly disorganized in 66cl4 and forces were not concentrated at the most leading
edge as with control cells (Figure 2.3(B)). Our results establish that a correlation does
exist between traction stress and the progression of metastatic abilities, such that cells
capable of completing different stages of the metastatic cascade, ultimately towards the
capacity to form secondary tumors, may gradually lose their ability to produce strong
traction stress and these forces appear to become less organized.
Cell-Substrate Adhesion Strength Correlates with Decreasing Traction Stress
Cell-substrate adhesion is critical for the transmission of internal forces to the
substrate resulting in cell migration in two-dimensions, however how much adhesion is
enough for optimal migration appears to be cell type dependent (Palecek et al., 1997;
Schwartz and Horwitz, 2006; Mierke et al., 2008). Changes in cell-substrate adhesive
characteristics have long been implicated in the progression of cancer (Cavallaro and
Christofori, 2001; Lu et al., 2001; Mierke, 2008). Thus we have asked if the strength of
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adhesion changes with metastatic capacity and how this aligns with the measurements
of traction stress.
Using a centrifugation assay, we have tested the panel of metastatic breast
cancer cells for adhesion strength. Briefly, cells were plated onto fibronectin coated
polyacrylamide hydrogels and allowed to adhere for 30 minutes before being subjected
to centrifugal forces of 1800 x g for 5 minutes (Figure 2.3(C)). Consistent with previous
observations (Cavallaro and Christofori, 2001; Yeatman, 2004; Mierke, 2008), we found
that enhanced metastatic capacity indeed reduces cell-substrate adhesion strength in
two-dimensions. Furthermore, this inability to bind tightly to the extracellular matrix
correlates very well with the progressive reduction of traction stress as cells of this
panel acquire greater metastatic capacity. It is reasonable to presume this reduced
adhesion in the most metastatic cells results in lower traction stress.
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Figure 2.3. The productions of stress in two-dimension and adhesion strength are
inversely related to the metastatic capacity. (A) Average integrated traction stress
(Pascal) produced by the normal murine mammary gland cell line and the panel of mice
breast cancer cell lines on a polyacrylamide substrate coated with 5 µg cm –2 fibronectin
is depicted in bar graph (n = 15 cells). (B) Field of traction stress, shown as vectorial
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arrows within the boundary of the cell. In the highest metastatic cell (66cl4) stress is
scattered and distributed in small pockets of short-lived protrusions, whereas in the nonmetastatic cells (67NR) stress is concentrated in a single direction. (C) Cell–substrate
adhesion strength decreases as metastatic potential increases in a centrifugation assay.
Each bar represents mean ± s.e.m. from three separate experiments. The data is
expressed as a percentage of control as defined by a wild-type mammary epithelial cell.
The Number of Focal Adhesions Decrease with Increasing Metastatic Capacity
Efficient migration and traction result from cell appropriate adhesion and
contraction. Our results thus far suggest a decline in function of the adhesion and
contraction machinery as the cancer cell panel progresses in metastatic capacities. To
test this possibility we determined the number and distribution of focal adhesions and
actin in these cell lines by immunofluorescence (Figure 2.4(A)). We were surprised to
find that stress fibers were not aberrant in any of these cell lines, despite the reduction
in traction stress. Furthermore, we did not observe an aberrant morphology of individual
adhesions, they were of typical size and shape, as for wild-type cells. In addition, we
observed the ability of adhesions to mature from the front of the cell (defined by an
arbitrary line forward of the nucleus of a highly polarized cell) into the cell body and
found that for all cell lines an equal ratio was maintained such that 35% of the
adhesions matured into the cell body (Figure 2.4(B) and (C)). However, we did find a
reduction in the overall number of adhesions as the cells increased in metastatic
capacity, which dropped from an average number of 47 adhesions/wild-type cell to 14
adhesions per cell in the most metastatic line (Figure 2.4(B)). These results indicate
that as the cells of this panel progress in metastatic capacity they produce fewer focal
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adhesions for migration, perhaps progressing into a less adhesion-dependent mode of
migration.

Figure 2.4. Focal adhesion number, but not their maturation, is decreased during
metastatic progression. (A) Immunofluorescence analysis for a focal adhesion protein
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paxillin (top panel) and a cytoskeleton protein actin (bottom panel) indicates that focal
adhesion and stress fiber organization remain intact with metastatic progression. Scale
bar 10 µm. (B) A hypothetical line is drawn forward of the nucleus of a highly polarized
cell and the number of paxillin proteins forward (identified as the leading edge) and
behind the line (defined as the cell body) are calculated. The total number of paxillincontaining adhesions relative to those co-localized with actin stress fibers at the leading
edge and inside the cell body. (C) The mean ± s.e.m. of the number of mature focal
adhesions is represented in each bar, expressed as a percentage calculated from the
number of focal adhesions at the leading edge and inside the cell body (n = 15 cells).
Integrin Activation Decreases with Metastatic Capacity
Previous studies have found that the amount of available ligand can affect
adhesion strength and subsequent traction stress (Palecek et al., 1997; Garcia and
Boettiger, 1999; Maheshwari et al., 1999; Holub et al., 2003; Engler et al., 2004a). We
tested this response in the breast cancer panel by measuring the levels of active beta-1
integrin in each cell line grown on culture plates coated at three densities of fibronectin
(0.05, 0.26 and 5 μg/cm2), the higher being the concentration used for the TFM and
adhesion studies (Figure 2.5(A)). We chose to look at the active form of beta-1 integrin
because this subunit of integrin can engage both collagen and fibronectin fibers and
gave us a direct comparison of the degree of engagement with the substrate.
Interestingly we discovered the same inverse relationship between the amounts of
active beta-1 integrin such that the more metastatic cells had the lowest amount of
integrin activated (Figure 2.5(B)). These results provide an explanation for the weak
traction, adhesion and low adhesion numbers observed in the most metastatic cells, but
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could support the suspicion that the more highly metastatic cells may have switched to
less adhesion-dependent mode of migration.

Figure 2.5. Active β1 integrin at various concentrations of fibronectin. (A) Active β1
integrin was detected by western blot from lysates of cells cultured on 0.05 µg cm –2, 5
µg cm–2 fibronectin or without fibronectin. Blots were probed with an antibody against
mouse active β1 integrin. The level of GAPDH served as a load control. (B) Line graph
represents the normalized intensity of active β1 integrin bands (Y-axis) and cell type (Xaxis).
Collective Migration Decreases with Metastatic Ability
During migration cells move not only as single entities, but more often in groups
and clusters (Friedl et al., 2004). Cells migrating during metastasis have also been
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observed moving in many forms as single cells, and as small and large clusters (Bell
and Waizbard, 1986; Friedl et al., 2004). To test the migratory behavior of this panel
when influenced by cell-cell contacts, we used a standard scratch wound assay. In this
assay, the least metastatic cells filled in the wound within a 24 hour period (Figure
2.6(A)). The normal cells and 67NR served as controls filling the gap 100% and 62%
respectively, this healing ability progressively dropped with metastatic capacity to 32%
for the most metastatic cells (66cl4) (Figure 2.6(B)). Interestingly, all of the cancer lines
had cells that broke from the monolayer and migrated non-collectively to fill the wound,
with the exception of the most metastatic cell line, 66cl4 (Figure 2.6(B)), see movies 15, available from stacks.iop.org/PhysBio/8/015015/mmedia). Individual cells from this
panel did not leave the cell sheet, but maintained their cell-cell interactions to eventually
fill the wound after 48 hours.
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Figure 2.6. The rate of collective migration decreases with increasing metastatic
capacity. (A) Motility of a confluent monolayer of mouse breast cancer cell lines in invitro wound healing assay. Wound closure was monitored by phase contrast
microscopy at the indicated time points. Original magnification, 10×. Scale bar = 100
µm. (B) Percent of the wound gap filled was determined as the distance from the wound
origin, in µm, covered by cells in 24 h following initiation of the wound. Three
independent experiments are displayed in each bar, representing their mean value±
s.e.m.
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Single Cell Migration Rates Decrease with Metastatic Capacity in 2-D but Increase
in 3-D
Given the great distances traveled by successful metastatic cells, it is generally
believed that cancer cells are highly efficient in migration, indeed the majority of
previous studies conclude that the migration speed of cancer cells is superior to normal
cells in two-dimensions (Banyard and Zetter, 1998; Friedl and Wolf, 2003). Furthermore,
a recent study of HT1080 fibrosarcoma cells has found that the migration speed of
these cancer cells is even greater in three-dimensional culture systems compared to
two-dimensions (Fraley et al., 2010). Finally, a summation of our data finds that in twodimensions a gradual loss in adhesion occurs as metastatic abilities progress in the
panel, such a change may reflect a switch in these cells to less adhesion-dependent
migration that would result in greater migration rates in three-dimensional environments.
To test the relevance of this concept we have compared migration speeds and
persistence in two- and three-dimensions in both fibrin/fibronectin and collagen for the
entire breast cancer panel of cells.
To measure single cell migration in two-dimensional cultures, cells were grown
on fibronectin and collagen coated coverslips and time-lapse imaging was used to
record their migration. Consistent with the results of the scratch wound assay the linear
speed of single cells on fibronectin decreased from 51 microns/minute to 23
microns/minute as the metastatic capacity increased, a change of 45% (Figure 2.7(A)).
Furthermore, the low speeds did not appear to be dependent on the type of ECM as
nearly identical measurements were observed when tested on collagen coated slides
(Figure 2.7(B); see movies 6-9, available at stacks.iop.org/PhysBio/8/015015/mmedia).
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However, when the linear speed was measured in three-dimensional cultures of
fibrin/fibronectin clots (Brown et al., 1993) or collagen matrices (Niggemann et al., 2004)
the trend was clearly reversed such that speed increased with metastatic capacity
(Figure

2.7

(C)

and

(D);

see

movies

10-13,

available

from

stacks.iop.org/PhysBio/8/015015/mmedia). Interestingly the normal mammary gland
NmuMg cells were unaffected by the change in dimensions maintaining a rate of 40-45
microns/minute in either environment and for both ECM proteins. Likewise, 168FARN
remained unchanged under any condition. Those cells most affected by the change in
dimension were 67NR, 4T07 and 66cl4. A striking ligand dependent 3-dimensional
sensitivity was observed in the most metastatic cell line (66cl4) where its migration rate
between 3D fibrin/fibronectin and the collagen matrices went from 20 microns/minute to
50 microns/minute, while the change from two-dimensional collagen to threedimensional collagen jumped from 30 microns/minute to 50 microns/minute,
respectively.
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Figure 2.7. Highly metastatic cells migrate efficiently in three dimensions but not in two
dimensions. Linear migration speed of the panel of murine breast cancer cell lines on
two-dimensional (A) fibronectin- and (B) collagen-coated coverslips and in three
dimensions within (C) fibrin–fibronectin clot and (D) collagen gel using time-lapse video
microscopy. The average rate of migration expressed in µm min –1 for a period of 2 h.
The mean value ± s.e.m. from ten sets of images is represented by each bar.
Migration efficiency can be defined not just by the linear speed, but by how long
the cell maintains a trajectory, reflecting its persistence in a particular direction. Analysis
of the persistence in two- and three- dimensional cultures of both ECM compositions
defined low persistence across the entire panel when compared to normal mammary
gland epithelial cells and did not show a strong trend as the metastatic capacity increased
(Figure 2.8). However, a tremendous reduction in persistence was observed in all cells in
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three-dimensional culture systems, producing a 4 to 5 fold decrease and no evidence of
ECM selectivity (Figure 2.8).
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Figure 2.8. Directional persistence is reduced as metastatic capacity increases. The
average persistence of migration in two-dimensional (A) fibronectin- and (B) collagencoated plates and within three-dimensional (C) fibrin–fibrinogen clot and (D) collagen
gels. Persistence is expressed in min; each bar represents the mean value ± s.e.m.
from ten sets of images. Migration trajectories in two dimensions (E), (F) and three
dimensions (G), (H) over a period of 2 h. Each node represents a 10 min interval.
The results of both the single cell migration experiment and the scratch wound
confirm that in two-dimensions, the most metastatic cells lacked the migration efficiency
possessed by the least metastatic cells. However, when these same measurements
were taken in three-dimensional cultures the speed was greater and showed cell
specific ligand selectivity in this response. Oddly however, the persistence parameter
was low across the panel and exceedingly low in three-dimensions, perhaps due to
barriers created by the fibrous matrices. These results are suggestive of a lower
dependence on adhesion migration, one that does not rely on adhesion strength and
traction stress to pull the cell along, but could use instead amoeboid migration or some
hybrid variation of it.
DISCUSSION
Each step in the metastatic cascade selects for the most competitive cancer
cells. When a normal cell becomes tumorogenic and subsequently develops metastatic
properties, it incorporates several biochemical and biophysical changes (Guo and
Giancotti, 2004b; Lopez et al., 2008; Mierke, 2008; Kumar and Weaver, 2009a). Most of
these changes are associated with higher proliferation, efficient migration, reduced
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adhesion and traction (Cowin and Welch, 2007). In some cases, complete adhesion
independent or ameboid movement is developed (Sanz-Moreno et al., 2008). However,
it is not known if these changes are acquired in a stepwise manner as cells become
more and more metastatic. In this study we have asked if a relationship exists between
the metastatic stages and changes in migration, adhesion, and the production of
traction stress. We were able to address our question in vitro by using a panel of
isogenic murine breast cancer cells that originated from same tumor but possessing
increasing abilities to metastasize.
Previous studies (Munevar et al., 2001) on individual pairs of wild-type and
oncogenically transformed fibroblast cells found that traction stress was reduced in the
most transformed cell line. A separate study has found that metastatic sarcoma cells
produce higher traction stress as compared to parental non-metastatic cells (Rosel et
al., 2008). In our study the most metastatic cell line produced the least force compared
to the isogenic control cell. The differences between the studies may be explained by
the fact that our cells are epithelial derived carcinomas versus the fibroblast-derived
sarcomas. Alternatively, the degree of aggressiveness of the cells used in the different
studies could also provide an explanation. In our study the cell line 66cl4 is considered
a moderately aggressive metastatic cell line (Giancotti and Ruoslahti, 1999).
The strength of our study lies in the use of a panel of murine mammary breast
cancer cells as opposed to unrelated cell lines. This panel allows us to follow the
change in traction stress in progressively more metastatic cells. We were surprised at
the neatly graded decline in the magnitude of traction stress as the panel of cells
progressed in their ability to metastasize. One potential explanation for this step-wise
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decline is that a series of mutations targeting a group of genes involved in migration
pathways and machinery are accumulated as the cells become more metastatic (Yang
et al., 2004). However, this would imply that the mutational events were not random but
sequential and that one mutation targeting the process of migration defined the site of
the next mutation. If the mutations had been random, arbitrary magnitudes of stress
across the cell panel would have been observed. Another possible explanation is that
mutational events involved a repeated assault on a single key regulator of the process
of migration.

This idea would allow for random mutational events that may not

contribute to assaults on the migration system whilst providing opportunity for repeated
random assaults on the same gene or gene product within the migration system thus
explaining why we observed a step-wise decline in the traction.
The measurement of traction stress is essentially a read-out of the health of the
contractile system of the cell in a two-dimensional environment. Across the panel,
adhesions and stress fibers appeared morphologically normal. At a functional level, the
adhesions matured normally though the total number of adhesions per cell declined as
the metastatic ability increased. This is an obvious explanation for the decline in the
adhesion strength of the cell as a whole, which declined as the metastatic capacity
increased. These results suggest that the formation of adhesions become compromised
in the panel as metastatic capacity increases, yet if they are formed they will mature
properly. However, the question of why the number of adhesions decreases across the
panel remains to be answered. Part of the answer certainly lies in the reduced levels of
engaged beta-1 integrin observed in the most metastatic cells. Taken together, the
reduced level of active beta-1 engaging the substrate provides a causative explanation
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for the lack of adhesions, adhesion strength, as well as, traction stress, in the more
metastatic cells of the panel, and interestingly it changes very little in response to
changes in the amount of available ligand. This might suggest a gradual switch to a
less adhesion-dependent mode of migration.
Metastatic cells have often been compared to professional migratory cells,
including macrophages and neutrophils. These cells are known to have few adhesions
and move by less adhesion dependent mechanisms thus producing relatively weak
traction stress reflective of their stealth like migratory properties (Smith et al., 2007).
Alternatively one could argue that a tumor cell that has evolved to become aggressively
metastatic is an unhealthy cell and to expect it to have remained efficient in such a
highly orchestrated event as migration may be far reaching. Nonetheless, consistent
with the former argument, we find that migration rates in three-dimensional cultures are
much greater in the most metastatic cells than the least metastatic, a completely
opposite trend from the two-dimensional migration assays. These results coupled with
the two-dimensional observations of lower levels of activated beta-1, poor adhesion
strength, fewer adhesions and reduced traction might suggest we have documented the
gradual acquisition of less adhesion-dependent migration during the progression of
metastasis. Alternatively, we may be observing a switch in dependence upon another
ECM protein, however this is unlikely as migration rates for the most metastatic cells in
both collagen and fibronectin based matrices was increased in three-dimensions over
two-dimensions.

Yet

another

possible

explanation

is

the

activity

of

matrix

metalloproteases which are known to modify the ECM in three dimensions in front of
migrating cells (Sternlicht and Werb, 2001). This could explain the enhanced migration
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rates we observe in three-dimensions. Indeed, it has previously been reported that
66cl4 secrete more MMP compared to the least metastatic cell 67NR (Giancotti and
Ruoslahti, 1999).
Many cancer biologists believe that EMT is a requirement for a tumor cell to
leave the primary tumor and metastasize (Ke et al., 2008; Mani et al., 2008; Sarrio et
al., 2008). However, others have documented that in most cancers the complete loss of
epithelial markers and the gain of mesenchymal markers were rarely observed
(Christofori, 2006). In our study it was intriguing to find an incomplete expression of
mesenchymal markers throughout the entire panel despite the complete loss of the
epithelial marker E-Cadherin. The gain of the N-cadherin marker was only observed in
the cells that do not metastasize (67NR) and the cells with the greatest (66cl4) capacity
to metastasize. In spite of this agreement, the traction produced, and the adhesion and
migration properties of these two cells were diametrically opposed. While we certainly
have not exhausted the number of potential EMT markers nor can we speak to those
that have yet to be discovered, based on our results we do not find a correlation
between the EMT markers we have used and the degree of metastatic capacity.
Alternatively one could argue that mesenchymal type migration is an adhesiondependent mode of migration, and since the cancer panel may have progressed to less
adhesion-dependent migration, a full set of these markers may be irrelevant.

Our

observations support the contention that a complete epithelial-mesenchymal transition
is not an infallible hallmark in the gauging of metastatic capacity and that individual
marker are likely to vary as well.
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Figure 2.9. Summary of murine breast cancer cell panel and their abilities to migrate
and produce traction relative to metastatic capacity. Those cells that are the most
metastatic produce the weakest forces in two dimensions and migrate the least
efficiently, whilst in three dimensions, metastatic cells move more efficiently. These
results may reflect the evolution of a less adhesion-dependent form of migration as the
cells progress to greater metastatic abilities.
In summary, we have found an inverse correlation between traction stress and
metastatic capacity within a panel of breast cancer cell lines (see figure 2.9).
Furthermore, we have determined that this correlation extends to adhesive strength,
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migration speed and directional persistence in two-dimensional assays. In addition, we
have determined that these changes correlate, not with the morphology of cell-substrate
adhesions or their ability to mature, but likely their ability to engage the substrate
through beta-1 integrin activation as the cells become more metastatic. Finally, based
on three-dimensional migration assays we contend that as the metastatic capacity
increases in our cell panel, a switch to a less adhesion-dependent mechanism occurs.
Our results demonstrate for the first time a relationship between traction stress and the
progression of a disease, more specifically the metastatic state of cancer cells in-vitro.
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CHAPTER 3
AN IN-VITRO CORRELATION OF METASTATIC CAPACITY, SUBSTRATE RIGIDITY
AND ECM COMPOSITION
This chapter has been published
Indra, I., and Beningo, K.A. (2011b). An in-vitro correlation of metastatic capacity,
substrate rigidity, and ECM composition. Journal of cellular biochemistry, 112, 31513158. © 2011 Wiley-Liss, Inc.

ABSTRACT
The process of metastasis requires a metastatic cancer cell to invade a variety of
micro-environments of variable stiffnesses. Unlike metastatic cells, normal cell function
and viability is dependent on the stiffness of the environment and used as a cue to
maintain cell health and proper tissue organization. In this study we have asked if
metastatic cells can ignore the parameter of stiffness and if this ability is gradually
acquired and if so, through what mechanism. Using a panel of mouse mammary tumor
cells derived from the same parental tumor, but possessing different metastatic abilities,
we cultured the cells on hard and soft substrates conjugated with collagen or
fibronectin. Normal and non-metastatic tumor cells responded to changes in stiffness on
fibronectin, but not collagen. However the more metastatic cells ignored the change in
stiffness on fibronectin coated substrates. This lack of response on fibronectin
correlated with a change in the expression level of the α3 integrin subunit, activation of
the β1 subunit and phosphorylation of FAK at Y397. We conclude that through
fibronectin, changes in the activation and tethering of the beta-1 integrin provides a
mechanism for metastatic cells to disregard changes in compliance to survive and
navigate in environments of different stiffness.
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INTRODUCTION
The complex mixture of extracellular matrix proteins found in connective tissues
can create variability in the compliance of the extracellular matrix (ECM). Changes in
compliance are known to regulate cell adhesion (Juliano, 2002), migration (Lo et al.,
2000a), tumor invasion (Paszek et al., 2005), phagocytosis (Beningo et al., 2002b) and
development (Jiang et al., 2006a). Cells sense and respond to changes in matrix
compliance through a proposed feedback loop involving the internal contractile
mechanisms of the cell. Multiple cell-types are known to respond to substrate rigidity
including epithelial (Kostic et al., 2009), fibroblasts (Kostic and Sheetz, 2006), neurons
(Kostic et al., 2007), and muscle cells (Isenberg et al., 2009). The rigidity for optimum
function for a normal cell is thought to be dependent on its host tissue stiffness (Engler
et al., 2008) but this correlation is likely lost or modulated in highly migratory cells like
neutrophils (Yeung et al., 2005b), and in metastatic cells (Paszek and Weaver, 2004a)
which come in contact with various tissue rigidities. Previously it was shown that
oncogenic transformation resulted in rigidity-independent spreading and proliferation of
fibroblast and epithelial cells (Paszek et al., 2005). However, metastatic progression is a
complex multi-step process and single oncogenic transformation provides an
inadequate picture of how cells at different stages of this process might alter their
cellular behavior in response to changes in environmental rigidity. In addition, while the
protein composition of the ECM and matching cellular receptors are known to dictate
the cellular response to substrate rigidity (Rowlands et al., 2008), it is unclear how this
substrate-ligand specificity correlates with the rigidity sensing mechanism during
metastatic progression.
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Cell-ECM interactions are primarily mediated by the αβ heterodimeric,
transmembrane protein, integrin (Wegener and Campbell, 2008). Integrins act as a
conduit between extracellular ligands and the cytoskeleton (Janmey and McCulloch,
2007) and respond to the external substrate rigidity through a counter-response exerted
by the actomyosin network (Friedland et al., 2009). Integrins are mechanosensors and
undergo

conformational

changes

in

response

to

mechanical

force.

These

conformational changes lead to enhanced cell-ECM adhesion, focal adhesion formation,
cell spreading (Friedland et al., 2009) and FAKpY397 phosphorylation (Shi and
Boettiger, 2003). Among the integrin family, the β1 subunit of integrin has been
implicated in several key processes of malignant progression and metastasis (Park et
al., 2006) and known to interact with a repertoire of ECM ligands including collagen,
fibronectin, laminin and vitronectin (Wiesner et al., 2005). Integrin specificity arises from
its modular structure and the β1 subunit can heterodimerize with nine different alpha
subunits (Gong et al., 1997) to form the largest subfamily of integrins.
Integrin mediated extracellular cues are transduced internally through focal
adhesion components (Schwartz, 2001). Focal adhesion kinase (FAK), a cytoplasmic
tyrosine kinase, is a central signaling component of focal adhesions. Phosphorylation of
FAK relays integrin mediated signals to signaling pathways involved in modulating cell
adhesion (Avizienyte and Frame, 2005), migration (Gilmore and Romer, 1996), shape
(Martin et al., 2002), growth, proliferation (Pirone et al., 2006) and apoptosis (Frisch et
al., 1996). One of the tyrosine sites of FAK at 397 is auto-phosphorylated immediately
following integrin clustering (Wei et al., 2008). Most importantly, phosphorylation of FAK
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at Y397 is involved in rigidity sensing and fibroblasts that have a deletion of this residue
are unable to discriminate between hard and soft substrates (Wang et al., 2001b).
In this study, we have asked if cancer cells at increasingly aggressive stages of
the metastatic cascade, respond differently to changes in environmental rigidity and if
the response is ECM and integrin specific. Using a panel of murine breast cancer cell
lines derived from a single parental tumor, but possessing different metastatic potential,
we evaluated the area of cell spreading, and the expression levels of β1, α3 and α5
integrins and the level of FAKpY397 phosphorylation on substrates of different rigidities
coated with either collagen or fibronectin. We have found that metastatic progression
results in changes in mechanosensory behavior in a fibronectin dependent manner,
such that as the cells become more metastatic, their ability to differentiate between soft
and rigid substrates is lost on fibronectin. Furthermore, we have found that this ability to
ignore changes in compliance correlates with the activation of β1 integrin,
phosphorylation of FAK and upregulation in the expression of α3 integrin in the more
metastatic cells. Our results could suggest that as cancer cells progress in metastatic
potential, one of the parameters they optimize is the ability to ignore the changes in
compliance that would be encountered on their metastatic journey, a parameter that a
normal cell uses to maintain tissue organization.
MATERIALS AND METHODS
Cell Culture and Polyacrylamide Substrates
Four sub-populations of murine breast cancer cell lines derived from the same
primary tumor but possessing different metastatic potential (generous gift from Dr. Fred
Miller, Karmanos Cancer Institute), (Fig. 3.1) and a normal murine mammary gland cell
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line was purchased from ATCC. Cultures were maintained in Dulbecco’s Modified
Eagle’s Medium containing 10% fetal bovine serum (Hyclone, UT, USA), and
supplemented with100 U/ml penicillin, 2 mM L-glutamine, and 100μg/ml streptomycin.
Cells were grown in a standard culture incubator at 37°C with 5% CO 2. Polyacrylamide
hydrogels were conjugated with bovine collagen type I (BD Biosciences, MA, USA) or
bovine plasma fibronectin (Sigma, Saint Louis, USA) at 5μg/cm2 as described
previously (Beningo et al., 2002b). Laminin (BD Biosciences, MA, USA) at 5μg/cm2
conjugation was carried out as described earlier (Kaverina et al., 2002). Substrate
compliance was controlled by varying the concentration of N,Nmethylene-bisacrylamide. All substrates used in this study were either, 5% acrylamide and 0.1% bisacrylamide (7.69 ± 2.85 kPa) designated the hard substrate or 5% acrylamide and
0.04% (1.30 ± 2.85 kPa) referred to as soft substrate (Guo et al., 2006b).

Figure 3.1. Metastatic properties of the murine breast cancer cell lines. 67NR is nonmetastatic line and does not come out from the primary tumor. 168FARN line is invasive

53

and enters into the lymphatic vessel but unable to extravasate. 4T07 line can complete
all the steps of metastatic cascade but unable to form the secondary tumor. 66cl4 line
completes all the steps of metastasis and forms the secondary tumor.
Microscopy
An Olympus IX81 ZDC inverted microscope was used to acquire phase contrast
images. The objective lens used for these studies was the 10 X/0.25 NA CP-Achromat
lenses. Images of live cells were collected while the cells were maintained at 37ºC and
supplied with 5% CO2 on a custom built stage incubator.
Cellular Assay for Sensing Compliance
To test for cellular response to changes in the compliance of the polyacrylamide
substrates (described above) we measured the area of cell spreading. Briefly,
approximately 1X104 cells were seeded on to the ECM coated polyacrylamide
substrates (5% acrylamide and 0.1% or 0.04% bis-acrylamide) in previously described
chambers (Beningo et al., 2002b). The cultures were incubated overnight at
37ºC/5%CO2 in a culture incubator. After 24 hours, images of cells were captured at 40x
for each cell type, under each of the experimental conditions of substrate rigidity and
ECM ligand. Image J software (NIH) was used to quantify the average cell area.
Western Blot Analysis
To acquire enough protein for western analysis, cells were cultured on larger
polyacrylamide substrates prepared in an electrophoresis mini-gel casting unit. One of
the gel casting plates (10x8cm) was activated as previously described (Beningo et al.,
2002b) and the other plate was silanized for easy removal after casting. After
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polymerization the polyacrylamide gel was washed and coated with bovine plasma
fibronectin, collagen or laminin as described above. Cells were cultured to 70%
conﬂuency on the gels and were rinsed with ice cold 1X PBS and lysed in triple
detergent lysis buffer (2% NP40, 0.5% Deoxycholic acid and 0.2% SDS) along with
protease inhibitors (SIGMAFAST Protease Inhibitor, Sigma Aldrich, USA). The protein
content was determined by the DC protein assay (Bio Rad, USA) according to
manufacturer’s instructions. Samples (25μg of protein, unless otherwise specified) were
subjected to SDS-PAGE on 4-20% mini gels and trans-blotted onto PVDF membrane
(Millipore, CA, USA). The membrane was blocked for 2 hours at room temperature in
5% Non-fat Dry milk, 0.1% Tween-20 in TBS for Actin, active β1, and α5 and α3
integrin. For probing FAK phosphorylation, membranes were blocked in 5% BSA, 0.1%
Tween-20 in TBS. Membranes were incubated with primary antibody for 18 hours at
4°C [1:5000 mouse monoclonal actin (BD Pharmingen, CA, USA); 1: 500 mouse
monoclonal active anti-β1 integrin (BD Pharmingen, CA, USA; Clone 9EG7); 1:2500
Rabbit polyclonal anti-α5 integrin (Millipore, CA, USA); 1:500 mouse monoclonal anti-α3
integrin (BD Pharmingen, CA, USA); 1:1000 Rabbit polyclonal Anti-FAK[pY397]
(Invitrogen, CA, USA). The membranes were washed and incubated with the species
appropriate horseradish-conjugated secondary antibody (Abcam, Cambridge, MA, USA;
BD Pharmingen, CA, USA; GE Healthcare, Buckinghamshire, UK). Signals were
detected with the ECL plus detection kit (GE Healthcare, Buckinghamshire, UK).
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RESULTS
Changes in Compliance are Sensed Differently Dependent on the ECM and
Metastatic Ability
Collagen is the main component of mammary epithelial tissue and normal
epithelial cells express high levels of collagen receptor (Zutter et al., 1999). It has also
been shown that collagen deposition increases with the formation and development of a
tumor, resulting in a change of stiffness within the tumor and its stroma (Kass et al.,
2007). Based on this, we used hard and soft substrates coated with collagen type I to
test the cellular response to changes in compliance at various stages of metastatic
progression. Four murine breast cancer cell lines with different metastatic capacity
(Fig.3.1) and normal murine mammary gland cell line (NmuMg) were seeded onto the
substrates at equal concentrations. After culturing cells for 24 hours the average total
area the cells had spread under each of the conditions was calculated. We were
surprised to find that both normal and metastatic cell types showed no statistically
significant difference in cell area, spreading equally on soft and hard substrates (Fig 3.2
(A) and (B)). On collagen, the cell area was found to be approximately 0.003 mm 2 for all
the cell lines on both hard and soft substrates, with the exception of the most metastatic
line 66cl4 whose area is smaller at 0.002 mm 2 (Fig 3.2(B)).
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Figure 3.2. Normal and Metastatic cells did not detect changes in stiffness on collagen.
(A) Phase images of normal mammary gland cell line and entire panel of mice breast
cancer cell lines showing the morphology and spread area on collagen coated hard and
soft substrate. (B) Bar graph represents the quantified cell areas (mm 2) of the entire
panel on soft (blue bars) and hard (red bars) collagen coated substrates from three
independent experiments. Each bar represents the mean value +/- s.e.m. of thirteen
independent fields of images. (n=13).
This led us to test the rigidity response to other extracellular matrix components,
including fibronectin and laminin. We found, as previously described, the cell area of
normal cells was significantly reduced on fibronectin coated soft substrates compared to
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hard substrates (Fig. 3.3 (A) and (B)) indicating a fibronectin mediated response to
rigidity. On the contrary, as the cell types increased in metastatic potential, we observed
a statistically significant indifference of the cells to the hard or soft substrate (Fig. 3.3
(B)). A plot of the percent change between cell area of cells grown on fibronectin coated
hard and soft substrates reveals a 50% change in the normal cells, a 30% change in the
non-metastatic line (67NR) and less than a 5% change in area in the most metastatic
cell lines (Fig. 3.3 (C)). Similar results were also observed on laminin coated hard and
soft substrates (Fig.3.4 (A)-(C)). Together these results suggest an ECM dependent
suppression of the rigidity sensing process with metastatic progression.
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Figure 3.3. Normal cells, but not metastatic cells, detect changes in stiffness on
fibronectin coated hydrogels. (A) Phase images normal mammary gland cell line and
the entire panel of mice breast cancer cell lines showing the morphology and spread
area of cells on fibronectin coated hard and soft substrate. (B) Bar graph represents the
quantified cell areas (mm2) of the entire panel on soft (blue bars) and hard (red bars)
fibronectin coated substrates from three independent experiments. Each bar represents
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the mean value +/- s.e.m. of thirteen independent fields of images. (n=13). ** P<0.0004
and * P<0.014. (C) Bar graph represents the percentage change in cell area from hard
to soft substrate while cultured on fibronectin coated substrate.
Increased Activation of β1 Integrin by Metastatic Cells in Response to Fibronectin
Coated Soft Substrates
Our data suggest the ability of the more metastatic cells to ignore the sensing
mechanism is ECM dependent. An obvious mechanistic target is β1 integrin as it binds
to both collagen and fibronectin, but more importantly, multiple studies have found an
up-regulation of β1 integrin during metastasis (Park et al., 2006). However, it is not clear
if upregulation of β1 subunit in metastatic cells is substrate rigidity and ECM
composition dependent. In addition, β1 integrin is known to be a mechanosensors
(Litzenberger et al., 2010). Testing for expression of total β1 integrin can be misleading
as it does not reflect the amount of activated receptor, thus we used an antibody
specific to the activated β1 subunit to look for a change coherent with the cell spreading
response observed when the cell panel was cultured on collagen or fibronectin
substrates. These results were consistent with the trend observed in the cell area on
fibronectin and collagen coated soft substrates. In response to soft substrate, the
amount of active β1 integrin in metastatic cells increased as compared to normal and
non-metastatic cells on fibronectin (Fig.3.5.(B)) and remains the same on collagen
coated substrates (Fig. 3.5.(A)). However, on the rigid substrates, less activated β1
subunit was observed in the metastatic cells on both collagen and fibronectin (Fig. 3.5
(A) and B)) indicating that cell spreading in metastatic cells on rigid substrate could be
achieved by less ECM engagement. Together, our results suggest that as metastatic
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capacity increases, the more metastatic cells alter their ECM engagement to
compensate for changes in rigidity, something normal cells do not do.

Figure 3.4. Metastatic cells do not sense compliance on laminin coated hydrogels. (A)
Phase images of normal mammary gland cell line and the entire panel of mice breast
cancer cell lines showing the morphology and spread area of cells on laminin coated
hard and soft substrate. (B) Bar graph represents the quantified cell areas of the entire
panel on soft (blue bars) and hard (red bars) laminin coated substrates from three
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independent experiments. Each bar represents the mean value +/- s.e.m. of thirteen
independent fields of images. (n=13). *** P<0.0001 and * P<0.014. (C) Bar graph
represents the percentage change in cell area from hard to soft substrate while ECM
ligand is laminin.
FAK Phosphorylation Levels Differ in Metastatic Cells Compared to NonMetastatic Cells in Response to Substrate Rigidity
Phosphorylation of FAK on Y397 has previously been associated with
malignancy, cytoskeleton tension (Paszek et al., 2005) and cell spreading (Partridge
and Marcantonio, 2006b). Furthermore, this specific residue of FAK has been shown to
be auto-phosphorylated upon β1 integrin activation in a rigidity dependent manner (Wei
et al., 2008). Most importantly, phosphorylation of FAK at Y396 is specific to integrin
engagement to fibronectin, but not to integrin clustering (Shi and Boettiger, 2003). Given
our observations that on fibronectin coated substrates the cell area and amount of
active β1 integrin differs greatly in the metastatic versus the non-metastatic cells,
dependent on the substrate rigidity, we tested for a correlation with phosphorylation
levels of FAK. Western blot analysis was performed on lysates of each cell line grown
on fibronectin coated hard and soft substrates. Blots were probed with antibodies
specific to phosphorylated tyrosine 397 of FAK (Fig. 3.5 (B)). We found a similar trend in
response to hard and soft as observed for active β1 integrin, such that as cells
increased in metastatic potential, the level of Y397 phosphorylation dropped on the
more rigid fibronectin coated substrates, but levels increased on the soft substrate as
metastatic potential increased (Fig. 3.5 (B)). These results indicate that as these cells
acquire greater metastatic abilities they may override the rigidity sensing mechanism by
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manipulating the activation of a β1 integrin and consequently the levels of FAK
phosphorylation.

Figure 3.5. Ligand bound β1integrin expression and phosphorylation level of FAK at
Y397 is modulated in metastatic cells on fibronectin coated hydrogels, but not on
collagen. (A) Total and ligand bound 1 integrin was detected by western blot from
lysates of cells cultured on hard or soft hydrogel coated with 0.05µg/cm2 bovine type-I
collagen and fibronectin. Blots were probed with antibody against active 1 integrins. The
level of actin served as a load control. Data represent three independent experiments.
(B) FAKpY397 was detected by western blot from lysates of cells cultured on hard or
soft hydrogel coated with 0.05µg/cm2 fibronectin. Blots were probed with antibody
against mouse FAKpY397. The level of actin served as a load control. Data represent
three independent experiments.
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Correlation of the Expression of Alpha Subunits with Activation of β1 Integrin
Our data link the cellular response to fibronectin and substrate rigidity to
metastatic progression. More specifically, this response is mediated through the
regulation of β1 integrin activity. However, the β1 subunit can dimerize with various
alpha subunits, although its dimerization with the α5 subunit forms the most specific
integrin receptor for fibronectin (Roca-Cusachs et al., 2009). These data along with
previous reports (Nam et al., 2010; Roman et al., 2010) prompted us to determine if α5
is indeed the subunit responsible for the differential response we describe above.
We compared the total expression of the α5 integrin subunit in lysates from the
panel of murine metastatic cells grown on hard and soft substrates coated with
fibronectin. Western blot analysis revealed a subtle decline in the expression of α5 with
increasing metastatic abilities on the soft fibronectin coated substrates (Fig. 3.6).
Furthermore, little difference in the expression levels from the cell panel was observed
on hard substrates (Fig.3.6). Most importantly, a difference in the expression levels
between the non-metastatic and the metastatic cells was not strong, with the exception
of the downregulation observed on the soft substrates for the most metastatic line 66cl4.
These results did not correlate with those of the active β1 subunits profile under the
same conditions.
A less selective integrin receptor that interacts with fibronectin, as well as laminin
and collagen is the α3β1 integrin (Kreidberg, 2000). This integrin has been found to be
frequently overexpressed in breast cancer cells (Morini et al., 2000) and down
regulation of this receptor has been shown to reduce invasion in breast cancer cells
(Mitchell et al., 2010). Using the same approach as described above, we determined
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that expression levels of the α3 subunit in the metastatic panel (Fig.3.6). A subtle and
gradual increase in expression of α3 subunit was found in metastatic cells cultured on
rigid substrate. However, the expression of α3 integrin was found to be greatly
enhanced in metastatic cells as compared to non-metastatic cells (NmuMg and 67NR)
cultured on soft substrate. This data suggests that alpha3 subunit is overexpressed in
metastatic cells and potentially acts as a partner of beta1 integrin in transmitting
deregulated rigidity response.

Figure 3.6. Alpha-5 and alpha-3 integrin expression on fibronectin coated hydrogels.
(A) Alpha-5 and alpha-3 integrin was detected by western blot from lysates of cells
cultured on hard or soft hydrogel coated with 0.05µg/cm 2. Blots were probed with
antibody against mouse total 5 or 3 integrin. The level of actin served as a load control.
Data represent three independent experiments.
Together these results suggest that as cells progress in metastatic ability a
fibronectin dependent interaction involving the α3 and β1 integrin subunits provides a
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potential conduit to overcome the changing parameter of mechanical compliance that a
metastatic cell will encounter.
DISCUSSION
There are many cues used by a cell to maintain its proper place within a tissue,
however we know the least about the physical cues. We do know that normal cellular
function requires a cell to maintain a normal tensional environment to thrive
(Bershadsky et al., 2003b; Ingber, 2008). Unlike normal cells, a metastatic cell has
obviously ignored its mechanical environmental cues and will likely need to modulate
them as it encounters environments of variable mechanical properties during the
multiple stages of the metastatic cascade (Kumar and Weaver, 2009b). For instance, as
it leaves the tumor and enters the loose connective tissue it will move from a rigid
environment to a softer environment and must compensate for these changes in
compliance if it will survive (Parekh et al., 2011). In this study we have asked if the
response to mechanical compliance remains constant or varies as the tumor cells
progress in metastatic abilities. We have found that indeed this panel of breast cancer
cells has gradually evolved a mechanism to disregard compliance cues, in a fibronectin
dependent manner. In addition, we have also determined that modulation of expression
of α3β1, along with phosphorylation of FAK at tyrosine 397, correlates with the
metastatic cells ability to ignore the compliance cues.
To support our hypothesis, it was first important to determine that a cell
response, such as cell area, differed on hard and soft substrates for normal and nonmetastatic cells, and that this difference was gradually lost as cells progressed in
metastatic abilities. We were surprised that we did not see the anticipated response for
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collagen coated substrates as has been previously reported for normal and malignant
cells (Wang et al., 2000). One obvious explanation for this lack of response is that
epithelial cells normally interact with collagen type IV basement membrane, as well as
laminin and fibronectin, and not the collagen type I known to be a prevalent component
of stroma (Schedin et al., 2004). On the other hand, all of the cell types could normally
have exposure to fibronectin during their metastatic journey in in-vivo environments.
While the amount of fibronectin found in the basement membrane can vary, we have
previously shown that 67NR and NmuMg can produce fibronectin (Indra et al., 2011).
When we quantified the cell area on fibronectin substrates we observed a cellular
response to the change in stiffness, such that normal cells and the least metastatic cells
could sense the difference, while the most metastatic cells did not respond to the
change in stiffness. A similar response was also observed with the basement
membrane protein, laminin (Fig. 3.4). These data suggest that fibronectin and laminin
receptors, but not a collagen type I receptor are used by this cell panel to detect
substrate compliance. In addition, disregarding the compliance cues from the
environment as metastatic capacity progresses could be a strategy for maximizing
growth and motility.
In search of a mechanism for these abnormal responses by metastatic cells we
tested for the expression levels of beta-1 integrin on collagen and fibronectin coated soft
and hard substrates. This receptor was an obvious starting point because it is
expressed in breast epithelial cells, binds to fibronectin, collagen and laminin, and is
known to be a mechanosensor (Park et al., 2006; Litzenberger et al., 2010). We found
that the normal and non-metastatic cells cultured on fibronectin had less activated beta-
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1 integrin on the soft substrates, indicating less receptor-ligand engagement and likely
weaker cytoskeletal tension consistent with their cell response. Conversely, the
metastatic cells increased the amount of active beta-1 on the soft substrate, allowing
them to compensate for the change in rigidity and transmit a misleading mechanical
signal in order to thrive within fibronectin-rich, softer, foreign environment. On the rigid
substrate less activated β1 subunit was observed in the metastatic cells on both
collagen and fibronectin suggesting a less adhesion dependent spreading. Thus, highly
metastatic cells are able to modulate their activity to accommodate the compliance of
the environment and appear to use the fibronectin interaction through beta-1 integrin to
do so.
Engagement of the ECM may not necessarily translate to internal activation,
however tyrosine phosphorylation of focal adhesion kinase is known to regulate integrin
mediated downstream signaling events (Guo and Giancotti, 2004a). More specifically,
residue 397 on FAK is phosphorylated only when receptor-ligand tethering occurs
(Paszek et al., 2005; Wei et al., 2008). Our result on the activation status of β1 integrin
indicated greater integrin-fibronectin tethering on compliant substrate than on rigid
substrates in metastatic cells 4T07 and 66cl4. Indeed antibodies specific to the
phosphorylated tyrosine residue at 397 of FAK confirmed our finding that the extent of
integrin-fibronectin tethering increases in metastatic cells cultured on softer substrates.
Furthermore, reduced expression of phosphorylated FAK at 397 in metastatic cells on
rigid substrate correlates with the reduced expression of beta1 integrin activation,
suggesting less cytoskeletal tension and reduced adhesion dependent spreading.
However, integrin mediated fibronectin tethering was greater in normal and non-
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metastatic cells on harder substrates, suggesting that the β1 integrin signal regarding
the substrate rigidity was transduced. These data suggest that, metastatic cells
modulate their adhesion parameter through β1 integrin activation, FAK pY397, ECM
engagement and subsequent spreading in-order to migrate through the fibronectin-rich
environment in a rigidity independent manner.
Since integrin mediated adhesion is mediated not only by β subunit, we went on
to determine the potential α subunit partner of the β1 integrin responsible for this
mechanism. Surprisingly, the expression levels of the most potent and well
characterized fibronectin receptor, α5 subunit (Hemler, 1990), did not correlate with
spreading and activation of β1 integrin, suggesting it is not likely to pair with β1 integrin
in mechanotransduction. This result is also supported by previous finding that α5β1 is
involved in cell adhesion and not mechanotransduction (Roca-Cusachs et al., 2009).
Since, we have found a similar response of cell area on fibronectin and laminin coated
substrate we suspected an alpha partner that was common for both the ligands. The α3
subunit of integrin was a reasonable choice, as α3β1 tethers both laminin and
fibronectin and has been reported to upregulated in metastasis (Giannelli et al., 2002).
We have found the expression levels of the α3 subunit to be low in normal and nonmetastatic cells and increase rapidly in metastatic cells on softer substrate. Although,
the trend of α3 subunit expressions remain the same in rigid substrates, the changes in
expression pattern with increasing metastatic capacity is not drastic. These results
implicate α3 subunit as a potential partner of β1 integrin in fibronectin mediated sensing
of substrate stiffness.
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In summary, this panel of breast cancer cells provided a means to observe the
gradual ability of cancer cells to disregard changes in compliance. Normal epithelial
cells and the non-invasive cells (67NR) respect their boundaries through mechanical
and biochemical cues provided by the relatively stiffer basement membrane. However
as the cells become more invasive and move into the softer stroma they change their
ECM interactions such that differences in mechanical compliance are ignored.
In conclusion, we have found that as cancer cells progress in metastatic potential
they alter their ability to sense the rigidity of their environment and that they do so by
increasing the amount of active β1 integrin and FAK phosphorylation in a fibronectin
dependent manner.

70

CHAPTER 4
AN IN-VITRO CORRELATION OF METASTATIC CAPACITY AND DUAL
MECHANOSTIMULATION

ABSTRACT
Physiologically, cells are under the influence of multiple forms of mechanical
input. For example, a cell is subjected to mechanical forces from tissue rigidity, shear
and tensile stress, and transient applied strain. Significant progress has been made in
understanding the cellular mechanotransduction mechanisms in response to a single
mechanical parameter. However, our knowledge of how the cell responds to multiple
mechanical inputs has been limited. In this study we have tested the cellular response
to the simultaneous application of two mechanical inputs, substrate compliance and
transient stimulation. Our results suggest that cells will restrict their response to a single
mechanical input at a time and when provided with two mechanical inputs
simultaneously, one will dominate. In normal and non-metastatic mammary epithelial
cells we found that the cells respond to applied stimulation and will override compliance
cues in favor of the applied mechanical stimulus. Surprisingly, however, metastatic
mammary epithelial cell remain nonresponsive to either of the mechanical cues. Our
results suggest that within our assay system, metastatic progression may involve the
down-regulation of multiple mechanotransduction pathways.
INTRODUCTION
Mechanotransduction is a mechanism that regulates cellular behaviors during
development (Czirok et al., 2004; Krieg et al., 2008), tissue morphogenesis (Engler et
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al., 2006), wound healing (Desmouliere et al., 2005), and cancer cell invasion (Paszek
et al., 2005). A number of molecular players of this mechanosensitive pathway have
been identified. Examples include, integrins (Katsumi et al., 2004), stretch-activated ion
channels, (Brakemeier et al., 2002), cadherins (Muller, 2008), and focal adhesion
kinases (Leucht et al., 2007). With the assistance of other signal molecules working in
concert, the mechanical signals are converted into molecular responses. Examples of
these

responses

include

actin

polymerization,

integrin

activation,

tyrosine

phosphorylation and the secretion of signaling molecules for survival, adhesion,
proliferation and cell migration (Wang et al., 2001a; Paszek et al., 2005; Chaturvedi et
al., 2007). Nonetheless these responses arise upon the application of a single
mechanical stimulus. Our understanding of what occurs to these mechanotransduction
responses when multiple mechanical inputs are applied simultaneously is limited.
However, it has previously been reported that endothelial cell migration is positively
influenced when fluid shear stress is applied to cells on compliant substrates, but not on
rigid substrates (Song et al., 2009). Aside from this study little else is known of how
multiple mechanical cues are interpreted.
Cells in-vivo are exposed to complex biophysical cues which play important roles
in tissue patterning, development, and individual cell behavior (Deugnier et al., 1995;
Takahashi et al., 1997; Liu et al., 1999). The manner in which individual cells in a tissue
context respond to these extracellular cues and maintain the tissue architecture is
largely unknown. It is believed that cellular behavior changes to accommodate the
differences in extracellular biophysical cues that occur during the change of purpose
and development. For example, the tissue repair process is concomitant with the
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stiffening of the tissue. The change in compliance results from ECM synthesis and
pulling force that are exerted by the contractile myofibroblast. These factors work to
bring the wounded edge together (Hinz, 2007). Similarly, mammary gland development
involves the deposition of ECM and an accumulation of stromal fibroblast for the
formation of the ductal tree (Schedin and Keely, 2011). However, abnormal stiffening of
the tissue and excessive contractile force result in fibrosis during wound healing and
tumor formation in the breast (Tomasek et al., 2002; Paszek and Weaver, 2004b).
Given the importance of multiple mechanical cues in maintaining tissue integrity, it is
necessary to understand the cellular response when more than a single mechanical
input is received in both normal and disease contexts.
Previous studies have shown that cellular response to substrate compliance
(Flanagan et al., 2002; Yeung et al., 2005a) or tugging and pulling forces (Feneberg et
al., 2004; Sun et al., 2008) are cell type dependent. In this study we have developed a
novel two-dimensional in-vitro assay system to understand how cells respond to
substrate compliance and transient mechanical stimulation, simultaneously. We have
found that normal and non-metastatic mammary epithelial cells respond differently to
dual mechanical inputs as compared to metastatic mammary epithelial cells. When both
the mechanical cues are provided in a two-dimensional system, normal and nonmetastatic cells preferentially responded to transiently applied mechanical cues by
overriding the signal from the substrate compliance. Surprisingly, metastatic tumor cells
did not respond to either of mechanical cues. We interpret this to suggest that
metastatic progression could be associated with the down regulation of select
mechanosensors.
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MATERIALS AND METHODS
Cell Culture and Spheroid Preparation
Four sub-populations of murine breast cancer cell lines derived from the same
primary tumor, but possessing variable metastatic potential (generous gift from Dr. Fred
Miller, Karmanos Cancer Institute), and normal murine mammary gland cell line was
purchased from ATCC. Cultures were maintained in Dulbecco’s Modified Eagle’s
Medium containing 10% fetal bovine serum (Hyclone, UT, USA), and supplemented
with100U/ml penicillin, 2mM L-glutamine, and 100μg/ml streptomycin. Cells were grown
in a standard culture incubator at 37°C with 5% CO 2 supply. Multicellular spheroids were
prepared by culturing cells on agar coated 96-well plates. Briefly, 96-well plates are
coated with 50 µl of sterile 2% agar and UV sterilized for 15 minutes. Trypsinized cells
were resuspended in cell culture media and approximately 1X 10 4 cells/ ml were
pipetted into each well. For spheroid development the plate was placed on a rotating
platform rotating at 1.83 Hertz inside a humidified cell culture incubator.
Substrate Preparation
Polyacrylamide gels were prepared with modifications as described previously
(Beningo et al., 2002a; Menon and Beningo, 2011). The flexibility of the substrate was
manipulated by maintaining the total acrylamide concentration at 5% while varying the
bis-acrylamide concentration between 0.04% (1.30 ± 2.85 kPa, referred to as soft) and
0.1% (7.69 ± 2.85 kPa, referred to as hard) (Guo et al., 2006b). Each substrate was
embedded with 50µl of fluorescently labeled beads (0.2 µm spheres, carboxylatemodified). To create the modified culture well, a 20mm hole was drilled with 1mm
thickness to the bottom of a 60mm culture dish (Nunclon). A chemically treated
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coverslip (Beningo et al., 2002a) was then attached via vacuum grease to the bottom of
the culture dish. Approximately, 200µl of hard substrate solution treated with ammonium
per sulfate (APS) and TEMED was plated into the culture well filling half of the well
volume. A silanized coverslip (25 µm diameter) was placed on top of the solution
leaving a small gap on the opposite side of the well. A paramagnetic bead of 800µm
(Cospheric, CA, USA) was inserted through the gap formed between the top and bottom
coverslip, followed by 200µl of APS and TEMED treated soft substrate. The top
coverslip was gently moved over the top of the unpolymerized substrate to close the
gap. Before the gel polymerized, a magnet was used to position the paramagnetic bead
within the softer substrate and placing it approximately 100 µm away from the border of
the two substrate compliances (Fig. 4.1 (A) and (C)). Following polymerization, the top
coverslip was carefully removed. For cell adhesion, bovine plasma fibronectin (Sigma,
Saint Louis, USA) at a concentration of 5μg/cm 2 was conjugated on top of the
polyacrylamide substrate (Beningo et al., 2002b).
Application of the Mechanical Stimulus
Mechanical stimulation was applied as described earlier (Menon and Beningo,
2011) with slight modification. Briefly, the assay plate was positioned 0.05 cm above a
rare earth magnet of 12,000Gauss (25mm in diameter and 5.5mm in thickness). The
magnet was rotated below the culture plate at 160 rpm (2.6 Hz) in an orbital field of 2cm
on an orbital rotator (Barnstead, Roto Mix- Type 50800, USA). The distance of the
assay plate and the rotational speed of the magnet were adjusted based on the data
obtained from bead displacements previously observed from cultured fibroblasts
(described in result section).
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RESULTS
Designing an Assay for the Simultaneous Application of Two Mechanical Stimuli
The purpose of this study was to understand how cellular sensing to rigidity and
applied mechanical cues changes with metastatic progression. To answer this question,
we designed an in-vitro assay system where both the mechanical cues are provided
and manipulated. Variation in substrate compliance was provided by casting
polyacrylamide hydrogels of two different rigidities side by side (Fig. 4.1 (A-C)). The
entire substrate was conjugated with extracellular protein fibronectin to create a uniform
adhesive field for cell attachment. We chose fibronectin because we have previously
shown that compliance sensing properties by this panel of cell lines is fibronectin
dependent (Indra and Beningo, 2011b). To provide applied stimulation from the softer
part of the substrate, an 800µm paramagnetic bead was embedded within the soft
hydrogel and positioned 100 µm away from the border where the substrates of two
different rigidities meet. Transient mechanical pull was created from the softer part of
the substrate by placing the assay plate above a rotating rare earth magnet. The entire
assay set-up was placed within a tissue culture incubator. The non-metastatic and
metastatic breast cancer cell lines of the murine panel spheroids were placed at the
border of the two compliances (hard and soft) and the applied stimulus was created by
the rotating magnet.
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Figure 4.1. Substrate for an in-vitro assay of dual-mechanostimulation. (A) Schematic
of the culture well cast with soft and rigid polyacrylamide hydrogels side-by-side and
conjugated with bovine plasma fibronectin on the surface. A paramagnetic bead was
embedded within the compliant substrate and positioned approximately 100 µm away
from the border of the two substrates. The multicellular spheroid was placed on the
border of the two rigidities. A rare earth magnet rotated 0.5 cm below the assay plate.
The rotational path of the magnet is displayed as dotted lines. (B) The assay plate
before placing the spheroid on the substrate. (C) The assay plate magnified at 2X after
placing the spheroid on the substrate.
Physiological Relevance of Magnetic Stimulation
To understand the response of mammary epithelial cells to the contractile forces
generated by neighboring cells, we adjusted the stimulation in our assay system to
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physiologically equivalent of fibroblast cells. To do this, we first verified if the magnetic
stimulation can transiently displace the paramagnetic bead embedded within the soft
substrate (Fig. 4.2 (A)). We realized that a 12,000 Gauss rare earth magnet of 25mm in
diameter and 5.5mm in thickness is capable of producing approximately 800 Gauss
magnetic force if it rotates 0.5cm under the assay plate at 2.33 Hertz and completes a
2cm orbital diameter. When we simulated this setup under the microscope we observed
0.15-0.25µm and 0.17-0.28µm displacement of fluorescent microbeads in the x and y
plane respectively due to the transient pulling force caused by the paramagnetic bead
under magnetic tension. To determine the physiological significance of this pulling force,
a monolayer of mouse embryonic fibroblast (MEF) cells was cultured on the assay
substrate and the displacement of the embedded fluorescent microbead at the edge of
cell monolayer was recorded (Fig. 4.2 (B)). The fluorescent bead displacement due to
the contractile forces produced by MEF cells, was found to be in the range of 0.190.89µm and 0.09-0.21µm in x and y planes, indicating forces generated by the cells is
comparatively higher than that of the transient mechanical pulling caused by magnetic
stimulation in our assay. Furthermore, the data obtained using our assay system is
predicted to be more conservative than in-vivo situation because highly contractile
myofibroblast cells found in mammary gland associated stroma is reported to produce
higher contractile forces as compared to fibroblast (MEF) cells used for this study
(Wrobel et al., 2002).
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Figure 4.2. Bead displacement upon magnetic stimulation and cellular contraction. (A)
The displacement of a florescent microbead (0.2µm) embedded within the assay
substrate due to the pulling forces generated by the paramagnetic bead upon magnetic
stimulation. X and Y coordinates of the florescent microbead are shown while the
rotating magnet under the assay plate is on four equidistant positions of its rotational
path. (B) Bottom panel showing the merged images of a monolayer of mouse embryonic
fibroblast (MEF) cells and fluorescent microbeads (0.2µm) embedded within the assay
substrate. A bead approximately 100 µm away from the edge of the cell monolayer was
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outlined and magnified (25X). The displacement of the bead is shown in X-Y
coordinates on 2-D plane due to the contractile forces generated by MEF cells at 15
minute intervals.
Transient Mechanosensing Overrides the Compliance Sensing Properties in
Normal Mammary Epithelial Cells
Under normal physiological condition mammary epithelial cells are known to
encounter changes in substrate compliance and transient pulling force (Schedin and
Keely, 2011). Based on this, we first tested the response of normal murine mammary
gland cells (NmuMg) in our assay system (Fig. 4.3 (A) and Fig.4.4 (A)). For this
purpose, a multicellular spheroid of NmuMg was placed at the border of two compliant
hydrogels conjugated with fibronectin. After the adhesion of the spheroid to the
substrate, the assay plate was kept with or without constant magnetic stimulation for 36
hours. Images of cellular dissemination were taken before and after stimulation. The
distance of the cell disseminated from the spheroid was calculated by drawing a line
from the edge of the spheroid and plotted as a bar graph. Similar to our previous finding
(Indra and Beningo, 2011b), the dissemination of NmuMg cells was found to be
dependent on the rigidity of the substrate. When transient stimulation was not provided,
the edge of the disseminating NmuMg cells extended to 174 µm on the rigid half of the
substrate, in sharp contrast to a distance of 87 µm on the softer substrate (p<0.05)
(Fig. 4.3 (B)). Surprisingly, a transition in the pattern of cellular dissemination was
observed when transient stimulation was provided. The dissemination of NmuMg cells
from the spheroid was now 365 µm on the soft part of the substrate containing the
magnetic stimulation as compared to 206 µm on hard part of the substrate without
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magnetic stimulation (p<0.05) (Fig. 4.4 (B)). Given that normal mammary gland cells
have a low dissemination distance on softer substrate, unless the magnetic stimulation
is applied, suggests that the transient pulling and tugging overrides the compliance
sensing mechanism.
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Figure 4.3. Compliance guided cellular dissemination is lost with metastatic
progression. (A) Dissemination of cells from the multicellular spheroids without transient
stimulation at 0 hours (left lane) and 36 hours on soft (middle lane) and rigid (right lane)
substrate are shown for NmuMg and the panel of murine breast cancer cell lines. (B)
Bar graph represents the length of disseminated cells (µm) from the edge of the
spheroid after 36 hours. Red and blue bars represent the distance of disseminated cells
(in µm) on soft and rigid substrates, respectively. Each bar represents mean ± s.e.m.,
results from three separate experiments. * indicates p value <0.05.
Metastatic Progression Correlates with an Inability to Sense both Compliance and
Transient Mechanical Stimulation
We have previously shown that the ability of mammary epithelial cells to sense
changes in compliance decreases with the gain of metastatic capacity (Indra and
Beningo, 2011a). This led us to ask weather metastatic progression is also associated
with a progressive loss in the ability to sense transient tugging and pulling forces. We
tested the panel of murine breast cancer cell lines of varying metastatic potential in our
assay system. Without transient stimulation, 67NR and 168FARN cells disseminated 43
and 18 µm further on rigid substrate as compared to softer substrate (p<0.05) (Fig. 4.3
(B)). This result demonstrates that, as with NmuMg cells, 67NR and 168FARN cells
responded to substrate compliance. Furthermore, as we have reported earlier (Indra
and Beningo, 2011b), a gradual decline in compliance response was seen with
metastatic progression (Fig. 4.3 (A) and (B)). However, similar to our earlier finding
(Indra and Beningo, 2011b), this compliance dependent cellular dissemination is lost
when we tested the most metastatic cell line, 66cl4 (Fig. 4.3 (A) and (B)). When we
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provided transient stimulation, like normal mammary gland cells, the non-metastatic cell
lines (67NR and 168FARN) responded to the transient stimulation by overriding the
substrate compliance and disseminated into the soft substrate (Fig. 4.4 (A)). 67NR and
168FAR disseminated further 125 and 333 µm respectively, on softer substrate as
compared to on rigid substrate (p<0.05) (Fig. 4.4 (B)). However, the metastatic cell,
66cl4 neither sensed changes in compliance nor did they respond to the transient
stimulation (Fig. 4.4 (B)). Together these results suggest that the cells within this panel
lose their mechanosensing abilities for both compliance and transient tugging and
pulling as progress in metastatic capacity.
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Figure 4.4. Normal and non-metastatic cells, but not metastatic cells, sense transient
stimulation and override mechanical signals of substrate compliance. (A) Dissemination
of cells from the multicellular spheroids with transient stimulation at 0 hours (left lane)
and 36 hours on soft (middle lane) and rigid substrates (right lane). (B) Bar graph
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represents the length of disseminated cells (µm) from the edge of the spheroid after 36
hours of stimulation. Red and blue bars represent the distance of disseminated cells (in
µm) towards (on soft substrate) and away (on rigid substrate) from the stimulation,
respectively. Each bar represents mean ± s.e.m., results from three separate
experiments. * indicates p value <0.05.
DISCUSSION AND FUTURE DIRECTIONS
The importance of mechanical forces in regulating the cellular behavior has been
well established (Lansman et al., 1987; Vogel and Sheetz, 2006; Sniadecki, 2010).
However, many of these studies are concentrated on understanding the cellular
behavior in response to single mechanical stimulation. To advance our understanding of
how mechanical cues affect physiological systems where multiple biophysical cues are
present simultaneously, we must also study cell behavior in response to complex
mechanical environments. In this study we have provided two forms of mechanical
stimulation in the form of compliance and transient mechanical pull, and asked whether
cells can respond to these mechanical cues when delivered simultaneously. We have
correlated these mechanosensory responses with the metastatic progression.
Given the importance of microenvironmental compliance and transient
stimulation in mammary gland development and tumor progression we have tested the
influence of these mechanical inputs on normal murine mammary epithelial cells and a
panel of murine breast cancer cells. Our assay system was designed to provide
simplicity and physiological relevance to determine the cellular response to more than
one mechanical cue. Compliance of the soft and rigid part of the substrate was
optimized based on the physiological range of compliance reported during tumor
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formation (Butcher et al., 2009). The magnitude of transient stimulation provided in our
assay system was also optimized based on the contractile forces generated by a
monolayer of fibroblast cells. In addition, to understand the cellular response in tissue
context we have tested the mechanical cues on multicellular spheroids instead of using
individual cells.
We have previously shown that the ability to sense changes in compliance
decreases gradually as cells become more metastatic (Indra and Beningo, 2011a).
However, in this present study, when the transient mechanical cue was provided along
with the compliance cue, as for normal cells, non-metastatic 67NR and 168FARN cells
responded to this applied cue by ignoring the substrate compliance. Surprisingly, highly
metastatic 66cl4 cells did not show any change in dissemination, as if the
mechanotransduction pathway was turned off. The inability to sense these mechanical
cues could result in the loss of directional migration in highly metastatic cells, as
previously described for cancer cell invasion and metastasis (Byers et al., 1991). From
these results we surmise that transient stimulation overrides the ability to sense
changes in compliance and unlike metastatic cells, tumorogenic, but non-metastatic
cells, retain normal sensing behavior. In addition, we can suggest that mammary
epithelial cells respond to one mechanical input at a time, but the dominance of the cue
could be cell type dependent. However, our study has been limited to two forms of
stimulation; it is also likely that a cell can respond to multiple mechanical inputs when
other combinations of biophysical cues are provided. It is also likely that any number of
biochemical factors would influence these observations, as the biophysical and
biochemical systems are not independent.
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Our simple assay system provides an in-vitro methodology for the application of
more than one mechanical cue. In the future, it will be important to determine the
cellular response to different combination of multiple mechanical cues using in-vitro and
in-vivo approaches. Furthermore, future studies will be needed to identify the
mechanosensors and the transduction pathways involved in sensing the transient
stimulation and how this pathway is influenced in metastatic progression. We have
previously shown that the status of integrin β1 activation and phosphorylation of FAK at
tyrosine 397 is involved in sensing the substrate compliance (Indra and Beningo,
2011b). From increased dissemination and migration of normal and non-metastatic cells
on softer substrate we would predict that in the presence of transient stimulation, the
sensing of cellular compliance is turned off by over activation of β1 integrin and
subsequent increased phosphorylation of FAKp397. Thus it is reasonable to test the
status of the active form of integrin β1 and FAKp397 in cells disseminated on softer
substrate in response to applied stimulation. It is also possible that other
mechanosensory molecules could be involved in sensing the transient stimulation and
activation could result in over activation of β1 integrin, increased FAKp397 and
deregulated compliance sensing. In addition, the β3 subunit of integrin has been shown
to be the mechanosensor (Jiang et al., 2006b), hence a next logical step would be to
determine the localization and activation of β3 integrin in response to transient
stimulation.
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CHAPTER 5
SUMMARY AND CONCLUSIONS
In this dissertation, I have investigated the correlation of metastatic progression
with changes in cellular and extracellular biophysical properties. In Chapter 2, I have
demonstrated that an inverse relationship exists between metastatic capacity and
cellular force production ability. Using a panel of murine breast cancer cell lines I found
that with the progression of metastatic capacity, a cell switches to a less adhesive mode
of migration. This results in decreased traction stress, adhesion strength, migration
speed, focal adhesion at the leading edge and β1 integrin activation in two-dimensional
in-vitro setup. However, this less adhesive mode of migration enables the highly
metastatic cells to migrate faster in an in-vitro three-dimensional environment. I
concluded that traction stress, adhesion strength and rate of migration do indeed
change as tumor cells progress in metastatic capacity and do so in a dimension
sensitive manner. In chapter 3, I set out to determine changes in cellular response to
substrate compliance as a cell becomes metastatic. The results showed that
compliance sensing properties of mammary epithelial cell decrease with metastatic
progression in ECM composition dependent manner. I have shown that fibronectin but
not type I collagen transmits the extracellular rigidity response inside the cell by
interacting with integrin α3β1 and FAKp397 phosphorylation. I have also demonstrated
that over activation of integrin α3β1 and increased phosphorylation of FAK at tyrosine
397 in metastatic cells results in a down regulation of compliance sensitive behavior. In
the third part of this thesis (chapter 4), I went one step further to determine the cellular
response to more than one mechanical cue- substrate compliance and transient
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stimulation. My data showed that normal and non-metastatic mammary epithelial cells
are responsive to one mechanical cue at a time of the cues selected and when both the
cues are provided, transient cue overrides the substrate compliance. However,
metastatic cells showed nonresponsiveness to both the cues.
I concluded that cellular mechanical characteristics and cellular response to
variations in extracellular mechanical cues change gradually with the gain of metastatic
characteristics.
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Mechanical forces play an important role in the regulation of cellular behavior and
physiological processes including adhesion, migration, proliferation, tissue repair,
embryogenesis and development. In addition, a number of diseases including cancer,
have been linked to changes in cellular and extracellular mechanical properties.
However, whether a correlation exists between the progression of cancer towards
metastasis and mechanical factors has not been clearly defined. Additionally, how a cell
responds to changes in extracellular mechanical cues as it gains metastatic abilities is
poorly understood. To address these questions, we have utilized a panel of murine
breast cancer cell lines with progressive metastatic capacity. We have asked how the
cell’s ability to produce mechanical forces changes as the cells progress in metastatic
abilities. Furthermore we have asked if metastatic progression changes the cells’ ability
to respond to altered extracellular mechanical cues in two-dimensional in-vitro cultures.
Our results indicate that with metastatic progression, the strength of adhesion and
traction stress progressively decreases. Furthermore we observe a downward trend in
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the number of focal adhesions at the leading edge, and subsequent reduction in the
activation of integrin β1 and migration speed. We have also found that this cell panel
loses its ability to sense changes in compliance as metastatic abilities increase and that
this occurs in a fibronectin dependent manner. We found that the loss in mechanical
sensing is associated with a decrease in integrin (α3)β1 activation and FAKpY397.
Finally, we showed that when a transient mechanical cue is provided, and coupled to
changes in compliance, normal and non-metastatic cells respond preferentially to the
transient cue. However, the metastatic cells neither sensed changes in compliance, nor
did they respond to the transient stimulation. Together these results show that a cell’s
ability to produce mechanical force, and sense extracellular mechanical forces,
progressively decrease with the gain of metastatic characteristics.
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